Home
  >  
Section 49

EurekaMag PDF full texts Chapter 48,140



References:

Anonymous 1958: ANOTHER renal symposium. Lancet 2(7040): 247-248
Anonymous 1959: ANOTHER winter of bronchitis. British Medical Journal 2(5159): 1076-1077
Smilde, A.K.; Jansen, J.J.; Hoefsloot, H.C.J.; Lamers, R.-J.A.N.; van der Greef, J.; Timmerman, M.E. 2005: ANOVA-simultaneous component analysis (ASCA): a new tool for analyzing designed metabolomics data. Bioinformatics 21(13): 3043-3048
Anonymous 1957: ANOXIA and cerebral damage. Lancet 273(6994): 529-530
Perry, T.L. 1952: Treatment of tuberculous meningitis in children. Journal of Pediatrics 40(6): 687-707
Anonymous 1951: ANOXIA in the newborn. Lancet 2(6688): 821-822
Zhang, L.; Cheng, L.; He, M.; Hu, B.; Wu, T. 2006: ANP T2238C, C-664G gene polymorphism and coronary heart disease in Chinese population. Journal of Huazhong University of Science and Technology. Medical Sciences 26(5): 528-530
Hirsch, J.R.; Meyer, M.; Forssmann, W.-G. 2006: ANP and urodilatin: who is who in the kidney. European Journal of Medical Research 11(10): 447-454
Moriyama, N.; Taniguchi, M.; Miyano, K.; Miyoshi, M.; Watanabe, T. 2006: ANP inhibits LPS-induced stimulation of rat microglial cells by suppressing NF-kappaB and AP-1 activations. Biochemical and Biophysical Research Communications 350(2): 322-328
Weber, N.C.; Blumenthal, S.B.; Hartung, T.; Vollmar, A.M.; Kiemer, A.K. 2003: ANP inhibits TNF-alpha-induced endothelial MCP-1 expression--involvement of p38 MAPK and MKP-1. Journal of Leukocyte Biology 74(5): 932-941
Misono, K.; Ogawa, H.; Qiu, Y.; Ogata, C.M. 2005: ANP receptor structure and signal transduction mechanism: a novel hormone-induced rotation mechanism for transmembrane signaling. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 50(9): 1078-1087
Li, P.; Oparil, S.; Novak, L.; Cao, X.; Shi, W.; Lucas, J.; Chen, Y.-F. 2007: ANP signaling inhibits TGF-beta-induced Smad2 and Smad3 nuclear translocation and extracellular matrix expression in rat pulmonary arterial smooth muscle cells. Journal of Applied Physiology 102(1): 390-398
Cuzzupoli, F.; Gazzano, A.M.; Moselli, M. 1962: ANP-235 (Lucidryl) as "reviving psychoregulator" in acute traumatic disorders of the brain. Minerva Anestesiologica 28: 118-123
Thuillier, J. 1960: ANP-235 (centrophenoxin), metabolic regulator. Concours Medical 82: 3717-3719
Sarvadi, D.G. 2002: ANSi APF tables are enforceable. Occupational Health and Safety 71(2): 8
Schmidt, M. 2006: ANSI/AAMi ES60601-1: a new approach to device standards. Biomedical Instrumentation and Technology 40(3): 246-247
Vaughan, V.C. 1952: Treatment of erythroblastosis fetalis. American Journal of Nursing 52(3): 320-322
Hyun, I.; Jung, K.Won. 2006: ANT vs. SCNT. Hastings Center Report 36(6): 6; Author Reply 7
Anonymous 1952: ANTABUSE (disulfiram) in the treatment of alcoholism. Journal of the American Medical Association 149(3): 275-277
Anonymous 1955: ANTACIDS for peptic ulcer. Lancet 268(6876): 1208
Anonymous 1960: ANTAGONISM between estrone and parathyroid extract in calcium metabolism of bone. Nutrition Reviews 18: 108-110
Fartoukh, M.; Similowski, T.; Brun-Buisson, C. 2004: ANTEAB: a study of early antibiotic therapy in intensive care management of acute exacerbations of chronic obstructive lung disease. Revue des Maladies Respiratoires 21(2 Part 1): 381-389
Sister Xavier Miriam 1953: Caring for souls in a catholic hospital. Hospital Progress 34(2): 60-61
Anonymous 1954: ANTENATAL Rh antibody tests. Journal of the American Medical Association 156(8): 772-773
Anonymous 1956: ANTENATAL care: a subject for discussion. Lancet 270(6929): 954
Anonymous 1956: ANTENATAL examination and care. Medical World 84(6): 499-502
Anonymous 1950: ANTEPARTUM haemorrhage. Irish journal of medical science 1950(300): 867-873
Anonymous 1952: ANTEPARTUM radiologic diagnosis of fetal abnormalities. Medical Radiography and Photography 28(1): 20-31
Danisawich, A.B. 1950: ANTHONY B. Danisawich 1897-1949. Diseases of the chest 18(6): 629
Woodroffe, A.J.W. 1951: ANTHONY James Warren Woodroffe. Lancet 1(6653): 535
Anonymous 1950: ANTHRAX in cattle. British Medical Journal 2(4674): 375
Collings, J.S. 1953: Group practice; existing patterns and future policies. Lancet 265(6775): 31-33
Anonymous 1957: ANTI-CHOLINE compounds. Nutrition Reviews 15(9): 277-278
Anonymous 1952: ANTI-HISTAMINE drugs and auricular fibrillation. Lancet 1(6704): 408
Anonymous 1959: ANTI-SNAKE-VENOM serum. Journal of the Indian Medical Association 33: 426-427
Frimodt Moller, J. 1951: The effect of PAS in Indian patient with pulmonary tuberculosis. Indian Medical Journal 45(2): 67-72
Grim, W.M.; Gordon, W.E. 1952: Comparative study of the disintergration time determination of compressed tablets according to the U.S.P. XIV and a modified British Pharmacopoeia (1948) method. American Journal of Pharmacy and the Sciences Supporting Public Health 124(12): 410-413
Anonymous 1952: ANTIBACTERIAL effect of cow's milk. Lancet 1(6703): 354-355
Anonymous 1952: ANTIBACTERIAL factor of milk. Nutrition Reviews 10(4): 118-119
Anonymous 1957: ANTIBACTERIAL treatment of primary tuberculosis. Lancet 273(6989): 286-287
Anonymous 1953: ANTIBACTERIALS and growth. Nutrition Reviews 11(10): 317-318
Anonymous 1953: ANTIBIOTIC and chemotherapeutic agents in the treatment of infantile diarrhoea and vomiting. Lancet 265(6797): 1163-1169
Anonymous 1951: ANTIBIOTIC combinations. New England Journal of Medicine 245(25): 989
Epps, P. 1957: Women in prison on attempted suicide charges. Lancet 273(6987): 182-184
Anonymous 1953: ANTIBIOTIC enterocolitis. Lancet 265(6798): 1245-1246
Daumezon, G. 1952: Action of the individual in psychotherapy in a social group. L' Evolution Psychiatrique 31(3): 475-506
Anonymous 1952: ANTIBIOTIC therapy in ambulatory surgery. Medical Times 80(11): 711-718
George, W.S. 1950: Anatomy of heart and great vessels. Medical Bulletin. United States. Army. European Command. Medical Division 7(12): 686-692
Fabricant, N.D. 1958: Favorable response of Bell's palsy to prednisone (meticorten). Eye Ear Nose and Throat Monthly 37(2): 116 Passim
Anonymous 1956: ANTIBIOTIC-RESISTANT staphylococci. Lancet 270(6926): 790-792
Anonymous 1954: ANTIBIOTIC-resistant micrococci (staphylococci). Journal of the American Medical Association 156(6): 608-609
Anonymous 1952: ANTIBIOTICS and B-vitamin requirements. Nutrition Reviews 10(4): 107-108
Anonymous 1959: ANTIBIOTICS and absorption. Nutrition Reviews 17(5): 146-147
Hall, H.E.; Hightower, J.A.; Diaz Rivera, R.; Byrne, R.J.; Smadel, J.E.; Woodward, T.E. 1951: Evaluation of antibiotic therapy in human leptospirosis. Annals of Internal Medicine 35(5): 981-998
Anonymous 1950: ANTIBIOTICS and comparative nutrition. Nutrition Reviews 8(11): 331-334
Anonymous 1956: ANTIBIOTICS and guinea pigs. Nutrition Reviews 14(6): 180-183
Anonymous 1960: ANTIBIOTICS and hospital infection. British Medical Journal 1(5165): 43-44
Anonymous 1957: ANTIBIOTICS and influenza. Journal of the American Medical Association 165(1): 58-59
Giolitti, G. 1957: Catalase activity and production of neomycin in Streptomyces fradiae. Nuovi Annali d'Igiene e Microbiologia 8(5): 572-577
Anonymous 1951: ANTIBIOTICS and monilial infection. Lancet 2(6682): 532
Anonymous 1955: ANTIBIOTICS and nitrogen metabolism. Nutrition Reviews 13(4): 117-118
Anonymous 1953: ANTIBIOTICS and rumen digestion. Nutrition Reviews 11(1): 9-10
Anonymous 1957: ANTIBIOTICS and sore throat. Lancet 272(6979): 1128-1130
Jones, W.C. 1953: Forgive us our debts. Southern Medical Journal 46(12): 1147-1151
Anonymous 1954: ANTIBIOTICS and sulfonamides. American Journal of Proctology 5(1): 56-58
Anonymous 1954: ANTIBIOTICS and the intestinal flora. Nutrition Reviews 12(8): 244-247
Anonymous 1956: ANTIBIOTICS and the intestine of the chick. Nutrition Reviews 14(3): 82-85
Anonymous 1954: ANTIBIOTICS as aids in meat production. Nutrition Reviews 12(4): 108-109
Anonymous 1953: ANTIBIOTICS as growth stimulators in ruminants. Nutrition Reviews 11(7): 208-210
Anonymous 1951: ANTIBIOTICS for turkey growth. Nutrition Reviews 9(12): 359-360
Anonymous 1953: ANTIBIOTICS in action. Lancet 1(6769): 1031-1032
Anonymous 1954: ANTIBIOTICS in avian nutrition. Nutrition Reviews 12(1): 13-14
Anonymous 1953: ANTIBIOTICS in cholera. Journal of the Indian Medical Association 22(7): 291
Anonymous 1957: ANTIBIOTICS in chronic bronchial infection. British Medical Journal 2(5042): 459-460
Anonymous 1953: ANTIBIOTICS in chronic respiratory infections. Lancet 1(6759): 529-530
Anonymous 1958: ANTIBIOTICS in hepatic coma. British Medical Journal 1(5069): 512
Anonymous 1953: ANTIBIOTICS in nature. British Medical Journal 1(4825): 1439-1440
Anonymous 1955: ANTIBIOTICS in old environment for chickens. Nutrition Reviews 13(6): 169-171
Russell, D.S. 1953: Histological changes in the striped muscles in myasthenia gravis. Journal of Pathology and Bacteriology 65(2): 279-289
Anonymous 1952: ANTIBIOTICS in the treatment of leptospirosis. British Medical Journal 2(4791): 986-987
White, P.D. 1957: The role of exercise in the aging. Journal of the American Medical Association 165(1): 70-71
Anonymous 1953: ANTIBIOTICS in whooping-cough. British Medical Journal 2(4839): 769-770
Anonymous 1953: ANTIBIOTICS, staphylococcal enteritis and pseudomembranous enterocolitis. New England Journal of Medicine 249(1): 37-40
Anonymous 1958: ANTIBIOTICS. I. General considerations and range of activity. New England Journal of Medicine 258(2): 85-86
Anonymous 1958: ANTIBIOTICS. II. Resistance. New England Journal of Medicine 258(7): 336-337
Anonymous 1958: ANTIBIOTICS. VI. Neomycin, polymyxin B, bacitracin and tyrothricin. New England Journal of Medicine 258(24): 1213-1215
Arnold, R.J. 1958: The aural rehabilitation center of the Navy. Medical Technicians Bulletin 9(3): 112-114
Anonymous 1958: ANTIBODIES in cells. Lancet 2(7059): 1269-1270
Anonymous 1958: ANTIBODY production in hepatic cirrhosis. British Medical Journal 1(5080): 1170-1171
Mcdonald, J.C.; Andrews, B.E. 1955: Diagnostic methods in an influenza vaccine trial. British Medical Journal 2(4950): 1232-1235
Anonymous 1960: ANTIBODY to penicillin. British Medical Journal 2(5196): 444-445
Anonymous 1958: ANTIBODY-ANTIGEN reactions observed by fluorescence. Lancet 1(7031): 1166
Anonymous 1958: ANTICHOLINE drugs. British Medical Journal 1(5075): 882
Anonymous 1955: ANTICHOLINERGIC drugs for peptic ulcer. British Medical Journal 1(4915): 711-712
Anonymous 1952: ANTICIPATION in inheritance of diabetes. Journal of the American Medical Association 150(8): 796-798
Goodwine, C.H. 1958: Determination of free available chlorine with field test kit. Medical Technicians Bulletin 9(2): 51-53
Anonymous 1950: ANTICOAGULANTS as a cause of hemorrhage. Journal of the American Medical Association 144(17): 1466-1467
Beaver, R.A. 1953: Adaptation of Bragg-Paul respirator. Lancet 265(6778): 200
Anonymous 1958: ANTICOAGULANTS in ischaemic heart disease. Medical World 88(4): 325-327
Brown, C.J. 1953: Diagnosis and treatment of congenital defects of the heart. Medical Journal of Australia 2(13): 508-510
Anonymous 1959: ANTICOAGULANTS: a cooperative effort. Journal of the American Medical Association 169(13): 1484-1486
Anonymous 1952: ANTICONVULSANT drugs in epilepsy. Medical World 76(18): 489
Anonymous 1953: ANTIDOTES for cyanide. British Medical Journal 1(4800): 36-37
Wohl, G.T. 1951: Role of x-ray diagnosis in study of nutritional disease. Pennsylvania Medical Journal 54(10): 975-976
Cooper, T.; Stickney, J.M.; Pease, G.L.; Bennett, W.A. 1952: Thrombotic thrombocytopenic purpura; confirmation of clinical diagnosis by bone marrow aspiration. American Journal of Medicine 13(3): 374-383
Macrae, A.D. 1957: Poliomyelitis studies in an isolated Scottish community. British Medical Journal 1(5015): 368-372
Anonymous 1958: ANTIGENIC response to polio vaccine. British Medical Journal 1(5063): 153
Anonymous 1958: ANTIHISTAMINES with an antiserotonin action. Triangle; the Sandoz Journal of Medical Science 3(7): 289-291
Alesen, L.A. 1952: The health needs of the nation. California Medicine 77(5): 344-348
Anonymous 1950: ANTISEPTICS and disinfectants. Manufacturing Chemist and Aerosol News 21(11): 477-479
Anonymous 1958: ANTISERUM gainst cancer. British Medical Journal 2(5101): 902
Anonymous 1958: ANTISPASMODICS and the gastrointestinal tract. Medical World 89(5): 434-437
Anonymous 1953: ANTITHYROTOXIC properties of dietary fat and liver residue in rats. Nutrition Reviews 11(9): 276-277
Anonymous 1956: ANTIVENIN (crotalidae) polyvalent. Journal of the American Medical Association 161(14): 1383-1384
Anonymous 1958: ANTIVIRAL chemotherapy. British Medical Journal 1(5082): 1290-1291
Lipp, W. 1951: Bilberry juice as a histologic stain. Mikroskopie 6(1-2): 32-40
Grant, R.L.; Antyllus 1961: ANTYLLUS, the elusive surgical genius of antiquity: an analysis of his writings. Surgery 50: 572-578
Anonymous 1960: ANURIA three weeks after myocardial infarction. New York State Journal of Medicine 60: 1621-1630
Stoney, R.A. 1955: Interns. IIi. Journal of the Irish Medical Association 36(213): 60-64
Szur, L.; Lewis, S.M.; Goolden, A.W. 1959: Polycythaemia. Lancet 1(7080): 988-989
Helfet, D.L.; Haas, N.P.; Schatzker, J.; Matter, P.; Moser, R.; Hanson, B. 2003: AO philosophy and principles of fracture management-its evolution and evaluation. Journal of Bone and Joint Surgery. American Volume 85(6): 1156-1160
Elmstrom, G.P. 1958: AO-Schepens binocular indirect ophthalmoscope. American Journal of Optometry and Archives of American Academy of Optometry 35(6): 335-336
Kriek, J.J.; Govender, S. 2006: AO-classification of thoracic and lumbar fractures--reproducibility utilizing radiographs and clinical information. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 15(8): 1239-1246
Proklov, V.V.; Sindler, Y.B. 2003: AO-spectrum analyzer implementation into CDMA-telecommunications with enhanced SIR-factors. IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control 50(7): 787-794
Todd, M.E. 2005: AOA Eye Care Benefits Center carefully watches coding issues. Optometry 76(5): 334-336
Light, T.R.; Swiontkowski, M.F. 2006: AOA Professionalism Guiding Leadership. Journal of Bone and Joint Surgery. American Volume 88(10): 2303-2304
Reeves, R.R. 2006: AOA certifying boards are credible and capable. Journal of the American Osteopathic Association 106(8): 441; Author Reply 441-2
Hayes, O.W. 2004: AOA membership and board certification of residency graduates: comparison of three programs accepting osteopathic physicians--implications for graduate medical education. Journal of the American Osteopathic Association 104(2): 82-86
Tatum, W.O. 2006: AOA needs to reach out more. Journal of the American Osteopathic Association 106(8): 442-443
Lubahn, J.D. 2004: AOA/AOS. the future of academic orthopaedics. Journal of Bone and Joint Surgery. American Volume 86(3): 641-643
Wang, Y-si.; Xin, J-yuan.; Li, Z-qing.; Wang, P-cai.; Wang, S-gong.; Wen, T-xue.; Sun, Y. 2006: AOD and angstrom parameters of aerosols observed by the Chinese sun hazemeter network from August to December 2004. Huan Jing Ke Xue= Huanjing Kexue 27(9): 1703-1711
Emerton, T. 2005: AOD expertise. Australian Nursing Journal 12(10): 3
Wilens, T.E. 1998: AOD use and attention deficit/hyperactivity disorder. Alcohol Health and Research World 22(2): 127-130
Michelson, J.D.; Speer, J.Adam. 2005: AOFAS member experience with computerization of the office. Foot and Ankle International 26(8): 645-655
Schmidt, K. 2004: AOK examiners chase physicians. MMW Fortschritte der Medizin 146(16): 55-56
Stiefelhagen, P. 2006: Melancholy in artistic diversity and expression. MMW Fortschritte der Medizin 148(14): 64
Goodman, T.; Chappy, S.; Durgin, L. 2005: AORN Foundation shares results of scholarship recipient survey. AORN Journal 81(3): 590-596
Anonymous 2005: AORN Guidance Statement: postoperative patient care in the ambulatory surgery setting. Aorn Journal 81(4): 881-888
Anonymous 2005: AORN Guidance Statement: preoperative patient care in the ambulatory surgery setting. Aorn Journal 81(4): 871-878
Linan-Thompson, S.; Vaughn, S.; Prater, K.; Cirino, P.T. 2006: The response to intervention of English language learners at risk for reading problems. Journal of Learning Disabilities 39(5): 390-398
Anonymous 2004: AORN bariatric surgery guideline. AORN Journal 79(5): 1026-40 1043-4 1047-52
Anonymous 2004: AORN guidance statement--safe medication practices in perioperative practice settings. Aorn Journal 79(3): 674-676
Anonymous 2005: AORN guidance statement: Fire prevention in the operating room. Aorn Journal 81(5): 1067-1075
Farrell, V.E.; Davies, K.A. 2006: Shaping and cultivating a perioperative culture of safety. AORN Journal 84(5): 857-861
Anonymous 2006: AORN guidance statement: The role of the health care industry representative in the perioperative setting. AORN Journal 83(4): 930 933-4
Beyea, S.C. 2005: Using trigger tools to enhance patient safety. AORN Journal 82(1): 115-116
Anonymous 2006: AORN guidance statement: creating a patient safety culture. Aorn Journal 83(4): 936-942
Wille, S. 2006: Urinary incontinence in men: male sling or artificial sphincter?. Aktuelle Urologie 37(6): 411-413
Anonymous 2006: AORN guidance statement: human and avian influenza and severe acute respiratory syndrome. Aorn Journal 84(2): 284-298
Anonymous 2005: AORN guidance statement: perioperative staffing. Association of peri Operative Registered Nurses. Aorn Journal 81(5): 1059-1066
Anonymous 2006: AORN guidance statement: safe medication practices in perioperative settings across the life span. Aorn Journal 84(2): 276-283
Anonymous 2005: AORN guidance statement: safe on-call practices in perioperative practice settings. Association of peri Operative Registered Nurses. Aorn Journal 81(5): 1054-1057
Beyea, S.C. 2004: Human patient simulation: a teaching strategy. AORN Journal 80(4): 738; 741-742
Anonymous 2005: AORN guidance statement: sharps injury prevention in the perioperative setting. AORN Journal 81(3): 662 665
Franko, F.P. 2004: The RN in the circulator role--a proactive approach. AORN Journal 79(3): 683-689
Hahn, J.J.; Butz, K.P.; Gavin, J.G.; Mills, R.S.; Welter, C.J. 2004: AORN nurse leaders provide insight into management issues. AORN Journal 79(3): 616-620
Springer, R. 2002: To brush or not to brush...?. Plastic Surgical Nursing: Official Journal of the American Society of Plastic and Reconstructive Surgical Nurses 22(4): 185-187
Thompson, G.T. 2005: The concept of presencing in perioperative nursing. AORN Journal 82(3): 465-466; 468
Anonymous 2006: AORN updates sterilization guideline. Or Manager 22(6): 21-22
Anonymous 1959: AORTIC homografts. Medical Journal of Australia 46(2): 652
Mason, R.E. 1951: Pheochromocytoma with false negative benzodioxane tests. American Journal of Medicine 11(4): 524-530
Anonymous 1960: AORTIC insufficiency--its cause?. American Practitioner and Digest of Treatment 11: 743-744
Himbert, J.; Scebat, L.; Kremer, R. 1956: Effect of orthostatism on circulation and kidney function in cardiacs. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 32(8): 423-430
Anonymous 1957: AORTIC rupture from feeding sweet peas. Nutrition Reviews 15(2): 57-58
Anonymous 1953: AORTIC stenosis. British Medical Journal 2(4837): 668
Anonymous 1959: AORTIC systolic murmur in older patients. British Medical Journal 1(5124): 777
Anonymous 1955: AORTITIS and aortic valve disease in rheumatoid arthritis. American Practitioner and Digest of Treatment 6(8): 1236-1239
Linksz, A. 1972: AOS, : John Green, theand the Reasonable Notation of Visual Acuity Measurements. Transactions of the American Ophthalmological Society 70: 314-327
Gupta, R.R.; Jain, S.K.; Varshney, M. 2005: AOT water-in-oil microemulsions as a penetration enhancer in transdermal drug delivery of 5-fluorouracil. Colloids and Surfaces. B Biointerfaces 41(1): 25-32
Engberts, J.B.F.N.; Fernandez, E.; García-Río, L.; Leis, J.R. 2006: AOT-based microemulsions accelerate the 1,3-cycloaddition of benzonitrile oxide to N-ethylmaleimide. Journal of Organic Chemistry 71(16): 6118-6123
Braveman, B. 2006: AOTA's statement on health disparities. American Journal of Occupational Therapy: Official Publication of the American Occupational Therapy Association 60(6): 679
Blanchard, S.A. 2006: AOTA's statement on obesity. American Journal of Occupational Therapy: Official Publication of the American Occupational Therapy Association 60(6): 680
Harris, E.D. 2004: AOmegaA membership: what does it mean?. PharosofAlphaOmegaAlpha-HonorMedicalSociety.AlphaOmegaAlpha 67(4): 1
Schneider, B.B.; Lock, C.; Covey, T.R. 2005: AP and vacuum MALdi on a QqLIT instrument. Journal of the American Society for Mass Spectrometry 16(2): 176-182
Ma, W.-l.; Ye, H.; Xin, J.-b.; Tao, X.-n.; Bai, M. 2005: AP-1 Decoy modulating MMP-2/TIMP-1 imbalance induced by bleomycin-A5 in pulmonary fibroblasts. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 23(4): 282-285
Huizar-López, R.; Santerre, A.; Madrid-Marina, V.; Peralta-Zaragoza, O.; Villalobos-Arámbula, A.; Islas-Rodríguez, A. 2002: AP-1 is present in nuclear extracts of lymphocytes from lepromatous leprosy patients. International Journal of Leprosy and other Mycobacterial Diseases: Official Organ of the International Leprosy Association 70(4): 274-277
Minarcik, J.C.; Golden, J.A. 2003: AP-2 and HNK-1 define distinct populations of cranial neural crest cells. Orthodontics and Craniofacial Research 6(4): 210-219
Zhou, R.; Chen, P.; Zhang, G.-S. 2004: AP-2 expression and significance in the lung cancer tissues. Zhong Nan da Xue Xue Bao. Yi Xue Ban 29(2): 195-197
Lim, J.H.; Booker, A.B.; Luo, T.; Williams, T.; Furuta, Y.; Lagutin, O.; Oliver, G.; Sargent, T.D.; Fallon, J.R. 2005: AP-2alpha selectively regulates fragile X mental retardation-1 gene transcription during embryonic development. Human Molecular Genetics 14(14): 2027-2034
Wang, X.; Bolotin, D.; Chu, D.H.; Polak, L.; Williams, T.; Fuchs, E. 2006: AP-2alpha: a regulator of EGF receptor signaling and proliferation in skin epidermis. Journal of Cell Biology 172(3): 409-421
Li, H.; Goswami, P.C.; Domann, F.E. 2006: AP-2gamma induces p21 expression, arrests cell cycle, and inhibits the tumor growth of human carcinoma cells. Neoplasia 8(7): 568-577
Hong, S.-M.; Frierson, H.F.; Moskaluk, C.A. 2005: AP-2gamma protein expression in intratubular germ cell neoplasia of testis. American Journal of Clinical Pathology 124(6): 873-877
Figarella-Branger, D.; Colin, C.; Chinot, O.; Nanni, I.; Baeza, N.; Fina, F.éd.ér.; Tong, S.; Eudes, N.; Quilichini, B.; Romain, S.; Metellus, P.; Fuentes, S.ép.; Barrié, M.; Boucard, C.él.; Fraslon, C.; Bonavita, M.-J.é; Martin, P.-M.; Ouafik, L.'H. 2006: AP-HM tumour tissue bank: molecular signature of gliomas. Medecine Sciences: M/S 22(Special Issue 1): 54-59
Rogers, R. 2004: APA 2002 ethics, amphibology, and the release of psychological test records: a counterperspective to Erard. Journal of Personality Assessment 82(1): 31-34; Discussion: 44-47
Nevin, J. 1996: The momentum of compliance. Journal of Applied Behavior Analysis 29(4): 535-547
Thompson, J.F.; Shaw, H.M. 2004: Should tumor mitotic rate and patient age, as well as tumor thickness, be used to select melanoma patients for sentinel node biopsy?. Annals of Surgical Oncology 11(3): 233-235
Bird, E.V.; Iannitti, T.; Christmas, C.R.; Obara, I.; Andreev, V.I.; King, A.E.; Boissonade, F.M. 2018: A Novel Role for Lymphotactin (XCL1) Signaling in the Nervous System: XCL1 Acts via its Receptor XCR1 to Increase Trigeminal Neuronal Excitability. Neuroscience 379: 334-349
Hyler, S.E. 2002: APA Online CME Practice Guideline for the Treatment of Patients with Major Depressive Disorder. Journal of Psychiatric Practice 8(5): 315-319
Whitcomb, D.C. 2005: APA Presidential Address: 2004. Pancreas 31(2): 105-107
Polak, D.; Hafner, C.; Briza, P.; Kitzmüller, C.; Elbe-Bürger, A.; Samadi, N.; Gschwandtner, M.; Pfützner, W.; Zlabinger, G.J.; Jahn-Schmid, B.; Bohle, B. 2019: A novel role for neutrophils in IgE-mediated allergy: Evidence for antigen presentation in late-phase reactions. Journal of Allergy and Clinical Immunology 143(3): 1143-1152.E4
Crow, T.; Tian, L.-M. 2003: Neural correlates of Pavlovian conditioning in components of the neural network supporting ciliary locomotion in Hermissenda. Learning and Memory 10(3): 209-216
Hyler, S.E.; Tahil, F.A. 2002: APA online CME: buprenorphine for office-based treatment of opiate dependent patients. Journal of Psychiatric Practice 8(6): 393-397
Dewdney, B.; Hebbard, L. 2018: A novel role for polymeric immunoglobulin receptor in tumour development: beyond mucosal immunity and into hepatic cancer cell transformation. Hepatobiliary Surgery and Nutrition 7(1): 52-55
Ni, B.; Farrar, J.S.; Chen, S.; Lownik, J.C.; Celi, F.S. 2018: A novel role for PTK2B in cultured beige adipocyte differentiation. Biochemical and Biophysical Research Communications 501(4): 851-857
Kaplan, R.M.; Spring, B.; Davidson, K. 2006: APA, NAMI, NMHA, and evidence-based behavioural medicine: a comment. Evidence-Based Mental Health 9(2): 32-34
Roberts, K.B.; Devries, J.M. 2004: APA/HRSA National Faculty Development Scholars Program: community-based teaching track. Ambulatory Pediatrics: the Official Journal of the Ambulatory Pediatric Association 4(1 Suppl): 92-97
Balci, C.; Sungurtekin, H.ül.; Gürses, E.; Sungurtekin, U.ğu. 2005: APACHE II, APACHE III, SOFA scoring systems, platelet counts and mortality in septic and nonseptic patients. Ulusal Travma Ve Acil Cerrahi Dergisi 11(1): 29-34
De Cássia Braga Ribeiro, K.; Kowalski, L.P. 2003: APACHE II, POSSUM, and ASA scores and the risk of perioperative complications in patients with oral or oropharyngeal cancer. Archives of Otolaryngology--Head and Neck Surgery 129(7): 739-745
Pryn, A.; Young, S. 2005: APACHE II: for one or for all?. International Journal of Obstetric Anesthesia 14(1): 81-82
Soriano, F.G. 2003: APACHE and Brazilian intensive care units. Sao Paulo Medical Journal 121(2): 43-44
Yeung, Y.P.; Lam, B.Y.K.; Yip, A.W.C. 2006: APACHE system is better than Ranson system in the prediction of severity of acute pancreatitis. Hepatobiliary and Pancreatic Diseases International: Hbpd Int 5(2): 294-299
Jones, F.A. 1957: Clinical and social problems of peptic ulcer. British Medical Journal 1(5021): 719
Anonymous 1960: APATHETIC hyperthyroidism. British Medical Journal 1(5167): 181-182
Ranganathan, S.; Subbiah, S.; Tan, T.W. 2002: APBioNet: the Asia-Pacific regional consortium for bioinformatics. Applied Bioinformatics 1(2): 101-105
Roura, S.; Martínez, D.; Piedra, J.; Miravet, S.; García de Herreros, A.; Duñach, M. 2003: APC 3 x 15 beta-catenin-binding domain potentiates beta-catenin association to TBP and upregulates TCF-4 transcriptional activity. Biochemical and Biophysical Research Communications 309(4): 830-835
Vodermaier, H.C.; Peters, J.-M. 2004: APC activators caught by their tails?. Cell Cycle 3(3): 265-266
Kariola, R.; Abdel-Rahman, W.M.; Ollikainen, M.; Butzow, R.; Peltomäki, P.äi.; Nyström, M. 2005: APC and beta-catenin protein expression patterns in HNPCC-related endometrial and colorectal cancers. Familial Cancer 4(2): 187-190
Cabrera, C.M.; López-Nevot, M.A. 2005: APC and chromosome instability in colorectal cancer. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 97(10): 738-743
du Sart, Dée. 2004: APC gene and familial adenomatous polyposis. Journal of Gastroenterology and Hepatology 19(5): 598
Bertario, L.; Russo, A.; Sala, P.; Varesco, L.; Crucianelli, R.; Frattini, M.; Pierotti, M.A.; Radice, P. 2004: APC genotype is not a prognostic factor in familial adenomatous polyposis patients with colorectal cancer. Diseases of the Colon and Rectum 47(10): 1662-1669
Arnold, C.N.; Goel, A.; Niedzwiecki, D.; Dowell, J.M.; Wasserman, L.; Compton, C.; Mayer, R.J.; Bertagnolli, M.M.; Boland, C.Richard. 2004: APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q. Cancer Biology and Therapy 3(10): 960-964
Duriez, R.; Roustan, R. 1962: APC virus diseases in French North Africa. Bulletin Mensuel - Societe de Medecine Militaire Francaise 56: 72-77
Mumme, C. 1956: APC virus infection; observations during the 1955 epidemic in Hamburg and a family epidemic of 1956 in Altona. Medizinische Klinik 51(12): 453-456
Sohier, R. 1956: APC virus infections in France; report of two recent small sources following grippe B. Bulletin de l'Academie Nationale de Medecine 140(7-8): 101-105
Parrott, R.H. 1956: APC viruses in respiratory diseases; clinical aspects. Laryngoscope 66(6): 628-636
Hsieh, J.-S.; Lin, S.-R.; Chang, M.-Y.; Chen, F.-M.; Lu, C.-Y.; Huang, T.-J.; Huang, Y.-S.; Huang, C.-J.; Wang, J.-Y. 2005: APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance. American Surgeon 71(4): 336-343
Bright-Thomas, R.M.; Hargest, R. 2003: APC, beta-Catenin and hTCF-4; an unholy trinity in the genesis of colorectal cancer. European Journal of Surgical Oncology: the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 29(2): 107-117
Pijnenborg, J.M.A.; Kisters, N.; van Engeland, M.; Dunselman, G.A.J.; de Haan, J.; de Goeij, A.F.P.M.; Groothuis, P.G. 2004: APC, beta-catenin, and E-cadherin and the development of recurrent endometrial carcinoma. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 14(5): 947-956
Strandberg, K.; Stenflo, J.; Nilsson, C.; Svensson, P.J. 2005: APC-PCi complex concentration is higher in patients with previous venous thromboembolism with Factor V Leiden. Journal of Thrombosis and Haemostasis: Jth 3(11): 2578-2580
Schmidt, K.N.; Leung, B.; Kwong, M.; Zarember, K.A.; Satyal, S.; Navas, T.A.; Wang, F.; Godowski, P.J. 2004: APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. Journal of Immunology 172(1): 138-143
Lori, F.; Kelly, L.M.; Lisziewicz, J. 2004: APC-targeted immunization for the treatment of HIV-1. Expert Review of Vaccines 3(4 Suppl): S189-S198
Sivaprasad, U.; Machida, Y.J.; Dutta, A. 2007: APC/C--the master controller of origin licensing?. Cell Division 2: 8
Perbal, B. 2004: APC: the toll road to continued high quality communication. Cell Communication and Signaling: Ccs 2(1): 7
Egusquiza, D. 2001: APCs give PFS professionals a chance to manage outside the box. Patient Accounts 24(5): 2
Lovitch, S.B.; Walters, J.J.; Gross, M.L.; Unanue, E.R. 2003: APCs present a beta(k)-derived peptides that are autoantigenic to type B T cells. Journal of Immunology 170(8): 4155-4160
Lewis, A.F. 2002: APCs: one year later. how are we coping?. Patient Accounts 25(2): 2-3
Durand, P.-Y. 2006: APD schedules and clinical results. Contributions to Nephrology 150: 285-290
Jandacek, R.J. 2005: APD-356 (Arena). Current Opinion in Investigational Drugs 6(10): 1051-1056
O'Sullivan, O.; Zehnder, M.; Higgins, D.; Bucher, P.; Grosdidier, A.; Notredame, Cédric. 2003: APDB: a novel measure for benchmarking sequence alignment methods without reference alignments. Bioinformatics 19 Suppl. 1: I215-I221
Chen, Z.-q.; Qian, Y.-f.; Shen, G.; Wang, G.-m. 2004: APdi and Odi estimated from substitute palate plane. Shanghai Kou Qiang Yi Xue 13(1): 13-16
Sak, S.C.; Harnden, P.; Johnston, C.F.; Paul, A.B.; Kiltie, A.E. 2005: APE1 and XRCC1 protein expression levels predict cancer-specific survival following radical radiotherapy in bladder cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(17): 6205-6211
Terry, P.D.; Umbach, D.M.; Taylor, J.A. 2006: APE1 genotype and risk of bladder cancer: evidence for effect modification by smoking. International Journal of Cancer 118(12): 3170-3173
Parsons, J.L.; Dianova, I.I.; Dianov, G.L. 2005: APE1-dependent repair of DNA single-strand breaks containing 3'-end 8-oxoguanine. Nucleic Acids Research 33(7): 2204-2209
Anonymous 1953: APES and men. British Medical Journal 1(4803): 208-209
Sridhar, V.V.; Surendrarao, A.; Liu, Z. 2006: APETALA1 and SEPALLATA3 interact with SEUSS to mediate transcription repression during flower development. Development 133(16): 3159-3166
Jaramillo, M.A.; Kramer, E.M. 2004: APETALA3 and PISTILLATA homologs exhibit novel expression patterns in the unique perianth of Aristolochia (Aristolochiaceae). Evolution and Development 6(6): 449-458
Dimakis, N.; Bunker, G. 1999: APEX: cross-platform analysis program for EXAFS. Journal of Synchrotron Radiation 6(Pt 3): 274-275
Zhang, C.-O.; Li, Z.-L.; Kong, C.-Z. 2005: APF, HB-EGF, and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis. Bmc Urology 5: 7
Frommeyer, G.; Fischer, R.; Deges, J.; Rablbauer, R.; Schneider, A. 2004: APFIM investigations on site occupancies of the ternary alloying elements Cr, Fe, and Re in NiAl. Ultramicroscopy 101(2-4): 139-148
Anonymous 2003: APHA calls for increases in funding for the nation's public health system. Public Health Reports 118(5): 480
Anonymous 1951: APHASIA, hemiplegia and cardiac involvement. American Journal of Medicine 10(1): 101-109
Anonymous 1957: APHTHOUS ulceration of mouth. British Medical Journal 2(5053): 1099-1100
Winston, L.G.; Pang, S.; Haller, B.L.; Wong, M.; Chambers, H.F.; Perdreau-Remington, F. 2004: API 20 strep identification system may incorrectly speciate enterococci with low level resistance to vancomycin. Diagnostic Microbiology and Infectious Disease 48(4): 287-288
Mathew, R.; Rajalakshmi, A.; Grillet, D.; Krishnan, V.S.; Madhusudhananan, S. 2006: Acute axonal polyneuropathy in an unventilated patient with sepsis. Journal of the Association of Physicians of India 54: 235-237
Gupta, S.B.; Pujari, S.N.; Joshi, S.R.; Patel, A.K. 2006: API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India. Journal of the Association of Physicians of India 54: 57-74
Anonymous 2006: API expert consensus document on management of ischemic heart disease. Journal of the Association of Physicians of India 54: 469-480
Wu, W.N.; Moyer, M.D. 2004: API-ionspray MS and MS/MS study on the structural characterization of bisbenzylisoquinoline alkaloids. Journal of Pharmaceutical and Biomedical Analysis 34(1): 53-66
Hosokawa, Y.; Suzuki, H.; Nakagawa, M.; Lee, T.H.; Seto, M. 2005: API2-MALT1 fusion protein induces transcriptional activation of the API2 gene through NF-kappaB binding elements: evidence for a positive feed-back loop pathway resulting in unremitting NF-kappaB activation. Biochemical and Biophysical Research Communications 334(1): 51-60
Tsuzuki, S.; Kimoto, Y.; Lee, S.; Sugawara, T.; Manabe, Y.; Inoue, K. 2018: A novel role for scavenger receptor B1 as a contributor to the capture of specific volatile odorants in the nasal cavity. Biomedical Research 39(3): 117-129
Ward, S.E.; O'Sullivan, J.M.; Drakeford, C.; Aguila, S.; Jondle, C.N.; Sharma, J.; Fallon, P.G.; Brophy, T.M.; Preston, R.J.S.; Smyth, P.; Sheils, O.; Chion, A.; O'Donnell, J.S. 2018: A novel role for the macrophage galactose-type lectin receptor in mediating von Willebrand factor clearance. Blood 131(8): 911-916
Raimondi, S.; Pedotti, P.; Taioli, E. 2006: APIKIDS: a cohort of children born after assisted reproductive technologies. Paediatric and Perinatal Epidemiology 20(5): 411-415
Pandolfi, P.P. 2007: APL as a paradigm in biomedical research: a journey toward the cure. Current Topics in Microbiology and Immunology 313: 1-2
Uchida, A.; Matsuo, K.; Tanimoto, M. 2005: APL during gefitinib treatment for non-small-cell lung cancer. New England Journal of Medicine 352(8): 843
Hornsten, A.; Lieberthal, J.; Fadia, S.; Malins, R.; Ha, L.; Xu, X.; Daigle, I.; Markowitz, M.; O'Connor, G.; Plasterk, R.; Li, C. 2007: APL-1, a Caenorhabditis elegans protein related to the human beta-amyloid precursor protein, is essential for viability. Proceedings of the National Academy of Sciences of the United States of America 104(6): 1971-1976
Anonymous 1952: APLASTIC anemia and chloramphenicol. Journal of the Medical Association of the State of Alabama 22(4): 112-113
Anonymous 1957: APLASTIC anemia from trichloroethylene-extracted feed. Nutrition Reviews 15(4): 107-109
Anonymous 1950: APLASTIC anemia with myeloid metaplasia. American Practitioner and Digest of Treatment 1(8): 867-870
Callahan, M.Ann. 2003: APN transitional care. Journal of Nursing Scholarship: An Official Publication of Sigma Theta Tau International Honor Society of Nursing 35(3): 205
Neff, D.F.; Madigan, E.; Narsavage, G. 2003: APN-directed transitional home care model: achieving positive outcomes for patients with COPD. Home Healthcare Nurse 21(8): 543-550
Brooten, D.; Youngblut, J.; Blais, K.; Donahue, D.; Cruz, I.; Lightbourne, M. 2005: APN-physician collaboration in caring for women with high-risk pregnancies. Journal of Nursing Scholarship: An Official Publication of Sigma Theta Tau International Honor Society of Nursing 37(2): 178-184
Anonymous 1953: APNOEA in anaesthesia. British Medical Journal 1(4815): 875-876
Akhmadeev, A.V. 2006: Morphogenetic effects of neonatal androgenization on neuron dendroarchitectonics in amygdala dorsomedial nucleus. Ontogenez 37(5): 394-397
Sofer, D. 2004: APNs: improved outcomes at lower costs: older adults with heart failure fare better with transitional care after hospitalization. American Journal of Nursing 104(9): 19
Chen, E.S.; Cendoroglo, M.S.; Ramos, L.R.; Araujo, L.M.Q.; Carvalheira, G.M.G.; de Lábio, R.W.; Burbano, R.R.; Payão, S.L.M.; de A C Smith, Mília. 2006: APO A-V-1131T-->C polymorphism frequency and its association with morbidity in a Brazilian elderly population. Clinical Chemistry and Laboratory Medicine 44(1): 32-36
Bucur, O.; Ray, S.; Bucur, M.C.; Almasan, A. 2006: APO2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy. Frontiers in Bioscience: a Journal and Virtual Library 11: 1549-1568
Chhabra, S.; Narang, R.; Lakshmy, R.; Das, N. 2005: APOA1-75 G to a substitution associated with severe forms of CAD, lower levels of HDL and apoA-i among northern Indians. Disease Markers 21(4): 169-174
Calandra, S.; Priore Oliva, C.; Tarugi, P.; Bertolini, S. 2006: APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency. Current Opinion in Lipidology 17(2): 122-127
Hubacek, J.A.; Skodova, Z.; Adamkova, V.; Lanska, V.; Bobkova, D.; Poledne, R. 2004: APOAV (T-1131>C) variant has no effect on mother's height in a large population study. Lipids in Health and Disease 3: 10
Franca, R.; Spadari, S.; Maga, G. 2006: APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 12(5): Ra92-Ra98
Holmes, R.K.; Malim, M.H.; Bishop, K.N. 2007: APOBEC-mediated viral restriction: not simply editing?. Trends in Biochemical Sciences 32(3): 118-128
Strebel, K. 2005: APOBEC3G and HTLV-1: inhibition without deamination. Retrovirology 2: 37
Soros, V.B.; Greene, W.C. 2006: APOBEC3G and HIV-1: strike and counterstrike. Current Infectious Disease Reports 8(4): 317-323
Suspène, R.; Sommer, P.; Henry, M.; Ferris, S.ép.; Guétard, D.; Pochet, S.; Chester, A.; Navaratnam, N.; Wain-Hobson, S.; Vartanian, J.-P. 2004: APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase. Nucleic Acids Research 32(8): 2421-2429
Sasada, A.; Takaori-Kondo, A.; Shirakawa, K.; Kobayashi, M.; Abudu, A.; Hishizawa, M.; Imada, K.; Tanaka, Y.; Uchiyama, T. 2005: APOBEC3G targets human T-cell leukemia virus type 1. Retrovirology 2: 32
Berkhout, B.; de Ronde, A. 2004: APOBEC3G versus reverse transcriptase in the generation of HIV-1 drug-resistance mutations. Aids 18(13): 1861-1863
Rogozin, I.B.; Basu, M.K.; Jordan, I.King.; Pavlov, Y.I.; Koonin, E.V. 2005: APOBEC4, a new member of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases predicted by computational analysis. Cell Cycle 4(9): 1281-1285
Moore, M.A. 2002: APOCP/APJCP Questionnaire Points for Discussion at the First APOCP General Conference - Is an Asian PacificOrganization for Cancer Control Warranted?. Asian Pacific Journal of Cancer Prevention: Apjcp 3(2): 181-182
Singh, P.P.; Singh, M.; Mastana, S.S. 2006: APOE distribution in world populations with new data from India and the UK. Annals of Human Biology 33(3): 279-308
Fukumoto, H.; Ingelsson, M.; Gårevik, N.; Wahlund, L.O.; Nukina, N.; Yaguchi, Y.; Shibata, M.; Hyman, B.T.; Rebeck, G.W.; Irizarry, M.C. 2003: APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis. Experimental Neurology 183(1): 249-253
Chalmers, K.; Wilcock, G.K.; Love, S. 2003: APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of a beta protein. Neuropathology and Applied Neurobiology 29(3): 231-238
Kim, M.; Bae, H.J.; Lee, J.; Kang, L.; Lee, S.; Kim, S.; Lee, J.E.; Lee, K.M.; Yoon, B.W.; Kwon, O.; Koo, J.S.; Kim, B.K. 2005: APOE epsilon2/epsilon4 polymorphism and cerebral microbleeds on gradient-echo MRi. Neurology 65(9): 1474-1475
Prince, J.A.; Zetterberg, H.; Andreasen, N.; Marcusson, J.; Blennow, K. 2004: APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42. Neurology 62(11): 2116-2118
Blazer, D.G.; Fillenbaum, G.G.; Gold, D.T.; Burchett, B.M.; Hays, J.C. 2003: APOE epsilon4 as a predictor of subjective quality of life in a biracial older person community sample. Journal of Aging and Health 15(4): 645-660
Koutsis, G.; Panas, M.; Giogkaraki, E.; Potagas, C.; Karadima, G.; Sfagos, C.; Vassilopoulos, D. 2007: APOE epsilon4 is associated with impaired verbal learning in patients with MS. Neurology 68(8): 546-549
Zhou, Z.; Hoke, A.; Cornblath, D.R.; Griffin, J.W.; Polydefkis, M. 2005: APOE epsilon4 is not a susceptibility gene in idiopathic or diabetic sensory neuropathy. Neurology 64(1): 139-141
Gureje, O.; Ogunniyi, A.; Baiyewu, O.; Price, B.; Unverzagt, F.W.; Evans, R.M.; Smith-Gamble, V.; Lane, K.A.; Gao, S.; Hall, K.S.; Hendrie, H.C.; Murrell, J.R. 2006: APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians. Annals of Neurology 59(1): 182-185
Scarmeas, N.; Habeck, C.G.; Stern, Y.; Anderson, K.E. 2003: APOE genotype and cerebral blood flow in healthy young individuals. JAMA 290(12): 1581-1582
Borroni, B.; Grassi, M.; Costanzi, C.; Archetti, S.; Caimi, L.; Padovani, A. 2006: APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk. American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry 14(12): 1022-1031
Jorm, A.F.; Mather, K.A.; Butterworth, P.; Anstey, K.J.; Christensen, H.; Easteal, S. 2007: APOE genotype and cognitive functioning in a large age-stratified population sample. Neuropsychology 21(1): 1-8
Gromadzka, G.; Barańska-Gieruszczak, M.; Ciesielska, A.; Sarzyńska-Dlugosz, I.; Członkowska, A. 2005: APOE genotype and serum cholesterol in predicting risk for early death from ischemic stroke in men and women. Cerebrovascular Diseases 20(5): 291-298
Klages, J.D.; Fisk, J.D.; Rockwood, K. 2005: APOE genotype, vascular risk factors, memory test performance and the five-year risk of vascular cognitive impairment or Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 20(5): 292-297
Sundström, A.; Marklund, P.; Nilsson, L.-G.; Cruts, M.; Adolfsson, R.; Van Broeckhoven, C.; Nyberg, L. 2004: APOE influences on neuropsychological function after mild head injury: within-person comparisons. Neurology 62(11): 1963-1966
Butters, M.A.; Sweet, R.A.; Mulsant, B.H.; Ilyas Kamboh, M.; Pollock, B.G.; Begley, A.E.; Reynolds, C.F.; DeKosky, S.T. 2003: APOE is associated with age-of-onset, but not cognitive functioning, in late-life depression. International Journal of Geriatric Psychiatry 18(12): 1075-1081
Araki, S.-I.; Koya, D.; Makiishi, T.; Sugimoto, T.; Isono, M.; Kikkawa, R.; Kashiwagi, A.; Haneda, M. 2003: APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes: results of a prospective observational follow-up study. Diabetes Care 26(8): 2416-2420
Moretti, E.W.; Morris, R.W.; Podgoreanu, M.; Schwinn, D.A.; Newman, M.F.; Bennett, E.; Moulin, V.G.; Mba, U.U.; Laskowitz, D.T. 2005: APOE polymorphism is associated with risk of severe sepsis in surgical patients. Critical Care Medicine 33(11): 2521-2526
Zhao, J.H.; Brunner, E.J.; Kumari, M.; Singh-Manoux, A.; Hawe, E.; Talmud, P.J.; Marmot, M.G.; Humphries, S.E. 2005: APOE polymorphism, socioeconomic status and cognitive function in mid-life--the Whitehall Ii longitudinal study. Social Psychiatry and Psychiatric Epidemiology 40(7): 557-563
Huang, X.; Chen, P.C.; Poole, C. 2004: APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease. Neurology 62(12): 2198-2202
Heyer, E.J.; Wilson, D.A.; Sahlein, D.H.; Mocco, J.; Williams, S.C.; Sciacca, R.; Rampersad, A.; Komotar, R.J.; Zurica, J.; Benvenisty, A.; Quest, D.O.; Todd, G.; Solomon, R.A.; Connolly, E.S. 2005: APOE-epsilon4 predisposes to cognitive dysfunction following uncomplicated carotid endarterectomy. Neurology 65(11): 1759-1763
Halford, J.; Mazeika, G.; Slifer, S.; Speer, M.; Saunders, A.M.; Strittmatter, W.J.; Morgenlander, J.C. 2006: APOE2 allele increased in tardive dyskinesia. Movement Disorders: Official Journal of the Movement Disorder Society 21(4): 540-542
Vodder, M. 1953: New form of collaboration between practising physicians. Meddelelser Fra Sundhedsstyrelsen. Denmark. Sundhedsstyrelsen. Beredskabsafdelingen 22: 1552-1556
Anonymous 1957: APOPLEXY of youth. Lancet 273(6997): 681
Huber, H.J.; Rehm, M.; Plchut, M.; Düssmann, H.; Prehn, J.H.M. 2007: APOPTO-CELL--a simulation tool and interactive database for analyzing cellular susceptibility to apoptosis. Bioinformatics 23(5): 648-650
Matzke, E.B.; Raudzens, L. 1968: Aposporous Diploid Gametophytes from Sporophytes of the Liverwort Blasia Pusilla L. Proceedings of the National Academy of Sciences of the United States of America 59(3): 752-755
Campion, D.; Hannequin, D. 2006: APP duplication causes autosomal dominant Alzheimer disease with cerebral amyloid angiopathy. Medecine Sciences: M/S 22(5): 468-469
Menéndez-González, M.; Pérez-Pinera, P.; Martínez-Rivera, M.; Calatayud, M.T.; Blázquez Menes, B. 2005: APP processing and the APP-KPi domain involvement in the amyloid cascade. Neuro-Degenerative Diseases 2(6): 277-283
Tesco, G.; Ginestroni, A.; Hiltunen, M.; Kim, M.; Dolios, G.; Hyman, B.T.; Wang, R.; Berezovska, O.; Tanzi, R.E. 2005: APP substitutions V715F and L720P alter PS1 conformation and differentially affect Abeta and AICD generation. Journal of Neurochemistry 95(2): 446-456
Heese, K.; Inoue, N.; Nagai, Y.; Sawada, T. 2004: APP, NGF and the 'Sunday-driver' in a Trolley on the Road. Restorative Neurology and Neuroscience 22(2): 131-136
Chen, Y.; Bodles, A.M.; McPhie, D.L.; Neve, R.L.; Mrak, R.E.; Griffin, W.S.T. 2007: APP-BP1 inhibits Abeta42 levels by interacting with Presenilin-1. Molecular Neurodegeneration 2: 3
Van Dam, D.; Vloeberghs, E.; Abramowski, D.; Staufenbiel, M.; De Deyn, P.P.P. 2005: APP23 mice as a model of Alzheimer's disease: an example of a transgenic approach to modeling a CNS disorder. Cns Spectrums 10(3): 207-222
Lloyd, G.M. 1951: Orf in the country. British Medical Journal 1(4715): 1144
Balme, H. 1953: Group-training in modern methods of rehabilitation. British Journal of Physical Medicine: Including its Application to Industry 16(2): 38-39
Anonymous 1952: APPARENT intestinal synthesis of carotene. Nutrition Reviews 10(2): 52-53
Anonymous 1960: APPEAL against G.M.C. dismissed. Lancet 2(7145): 309-310
Anonymous 1952: APPEAL from the G. M. C. Lancet 2(6728): 294
Diomede, F.; D'Aurora, M.; Gugliandolo, A.; Merciaro, I.; Ettorre, V.; Bramanti, A.; Piattelli, A.; Gatta, V.; Mazzon, E.; Fontana, A.; Trubiani, O. 2018: A novel role in skeletal segment regeneration of extracellular vesicles released from periodontal-ligament stem cells. International Journal of Nanomedicine 13: 3805-3825
Anonymous 1952: APPEAL to Privy Council fails. British Medical Journal 2(4778): 291
Lew, R. 2004: APPEAL: fighting for social justice in tobacco control among Native Hawaiians and Pacific Islanders through leadership and capacity building. Pacific Health Dialog 11(2): 239-242
Anonymous 1953: APPENDICITIS not diagnosed. Lancet 1(6760): 593-594
Zhang, X.; Zhuang, R.; Wu, H.; Chen, J.; Wang, F.; Li, G.; Wu, C. 2018: A novel role of endocan in alleviating LPS-induced acute lung injury. Life Sciences 202: 89-97
Jheng, J.-R.; Lau, K.-S.; Lan, Y.-W.; Horng, J.-T. 2018: A novel role of ER stress signal transducer ATF6 in regulating enterovirus A71 viral protein stability. Journal of Biomedical Science 25(1): 9
Anonymous 1959: APPETITE and growth stimulation by tumor diets in the tumor-bearing rat. Nutrition Reviews 17: 274-276
Anonymous 1954: APPETITE quotient and ad libitum feeding. Nutrition Reviews 12(10): 313-315
Stewart, A.G.; Barnum, D.A.; Henderson, J.A. 1950: Algal poisoning in Ontario. Canadian Journal of Comparative Medicine and Veterinary Science 14(6): 197-202
Short, L.C.; Cai, S.-S.; Syage, J.A. 2007: APPI-MS: effects of mobile phases and VUV lamps on the detection of PAH compounds. Journal of the American Society for Mass Spectrometry 18(4): 589-599
Anonymous 1953: APPLICANT studies. Journal of Medical Education 28(2): 85-86
Chessick, R.D.; Wasserman, E.M.; Huels, M.; Gerty, F.J. 1959: The psychiatric ward administrator. Mental Hospitals 10(3): 7-10
Wooldridge, W.R. 1950: The animal health trust. British Veterinary Journal 106(4): 133-139
Anonymous 1953: APPLICATION of stereoscopy to medical illustration. Medicine Illustrated 7(11): Suppl 2-6
Rocha E Silva, M.; Rothschild, A.M. 1955: Anaphylatoxin, histamine depletion and skin reactions in the rat. Nature 175(4466): 987-988
Anonymous 1950: APPLYING for state civil service positions. American Psychologist 5(12): 664-669
Hosch, S.E.; Olefsky, J.M.; Kim, J.J. 2006: APPLied mechanics: uncovering how adiponectin modulates insulin action. Cell Metabolism 4(1): 5-6
Tuller, J.V. 1952: Progress and trends in sex education in the United States. Journal of Social Hygiene 38(2): 68-83
Anonymous 1951: APPROACH to the study of poliomyelitis. American Journal of Public Health and the Nation's Health 41(10): 1288-1289
Meng, F. 2019: A novel role of HIF-1α/PROX-1/LYVE-1 axis on tissue regeneration after renal ischaemia/reperfusion in mice. Archives of Physiology and Biochemistry 125(4): 321-331
Anonymous 1953: APPROVED examining board in medical specialties: Advisory Board for Medical Specialties. Journal of the American Medical Association 153(4): 389-430
Anonymous 1951: APPROVED examining boards in medical specialties. Journal of the American Medical Association 147(5): 476-512
Anonymous 1955: APPROVED examining boards in medical specialties; Advisory Board for Medical Specialties. Journal of the American Medical Association 159(5): 441-483
Anonymous 1950: APPROVED hospital dental departments. Journal of the American Dental Association 41(2): 260-264
Anonymous 1952: APPROVED hospitals in Indiana. Journal of the Indiana State Medical Association 45(7): 629-652
Anonymous 1959: APPROVED internships. Journal of the American Medical Association 171: 675-706
Zhang, K.; Chen, Y.; Zhang, T.; Huang, L.; Wang, Y.; Yin, T.; Qiu, J.; Gregersen, H.; Wang, G. 2018: A Novel Role of Id1 in Regulating Oscillatory Shear Stress-Mediated Lipid Uptake in Endothelial Cells. Annals of Biomedical Engineering 46(6): 849-863
Yu, Y. 2018: A Novel Role of Ring Chromosomes as Evolutionary Drivers of Herbicide Resistance. Plant Physiology 176(3): 1892-1893
Youness, R.A.; Assal, R.A.; Abdel Motaal, A.; Gad, M.Z. 2018: A novel role of sONE/NOS3/NO signaling cascade in mediating hydrogen sulphide bilateral effects on triple negative breast cancer progression. Nitric Oxide: Biology and Chemistry 80: 12-23
Anonymous 1952: APPROVED medical schools in Canada. Journal of the American Medical Association 150(2): 137-138
Anonymous 1952: APPROVED medical schools in the United States. Journal of the American Medical Association 150(2): 131-137
Anonymous 1952: APPROVED names for drugs. Lancet 2(6743): 1042
Wu, M.; Takemoto, M.; Luo, H.; Xu, J.-J.; Lu, M.-H.; Kameyama, M.; Takumi, T.; Song, W.-J. 2018: A novel role of the antitumor agent tricyclodecan-9-yl-xanthogenate as an open channel blocker of KCNQ1/KCNE1. European Journal of Pharmacology 824: 99-107
Hogg, D.W.; Chen, Y.; D'Aquila, A.L.; Xu, M.; Husić, M.; Tan, L.A.; Bull, C.; Lovejoy, D.A. 2018: A novel role of the corticotrophin-releasing hormone regulating peptide, teneurin C-terminal associated peptide 1, on glucose uptake into the brain. Journal of Neuroendocrinology 30(4): E12579
Da Silva, P.; Manieri, F.Z.; Herrera, C.M.; Trent, M.S.; Moreira, C.G. 2018: Novel Role of VisP and the Wzz System during O-Antigen Assembly in Salmonella enterica Serovar Typhimurium Pathogenesis. Infection and Immunity 86(8)
Murugesan, Y.Prabha.; Alsadoon, A.; Manoranjan, P.; Prasad, P.W.C. 2018: A novel rotational matrix and translation vector algorithm: geometric accuracy for augmented reality in oral and maxillofacial surgeries. International Journal of Medical Robotics + Computer Assisted Surgery: Mrcas 14(3): E1889
Rahmatpour, A.; Goodarzi, N.; Moazzez, M. 2018: A novel route for synthesis of cross-linked polystyrene copolymer beads with tunable porosity using guar and xanthan gums from bioresources as alternative synthetic suspension stabilizers. Designed Monomers and Polymers 21(1): 116-129
Beckhaus, R.üd.; Lützen, A.; Haase, D.; Saak, W.; Stroot, J.ör.; Becke, S.; Heinrichs, J.ür. 2001: A Novel Route to Fulvene Complexes of Titanium-Diastereoselective Complexation of Pentafulvenes to Cyclopentadienyltitanium Fragments. Angewandte Chemie 40(11): 2056-2058
Zhang, Y.; Jiang, H. 2018: A novel route to improve methane aromatization by using a simple composite catalyst. Chemical Communications 54(73): 10343-10346
Liang, K.; Zhao, Z.-W.; Zhou, X.; Xu, A.-W. 2018: A novel route to prepare N-graphene/SnO2 composite as a high-performance anode for lithium batteries. Dalton Transactions 47(30): 10206-10212
Nicolaou, K.C.; Baran, P.S.; Jautelat, R.; He, Y.; Fong, K.C.; Choi, H.-S.; Yoon, W.H.; Zhong, Y.-L. 1999: A Novel Route to the Fused Maleic Anhydride Moiety of CP Molecules. Angewandte Chemie 38(4): 549-552
Sun, W.; Gao, L.; Sun, X.; Zheng, G. 2018: A novel route with a Cu(ii)-MOF-derived structure to synthesize Cu/Cu 2 O NPs@graphene: the electron transfer leads to the synergistic effect of the Cu(0)-Cu(i) phase for an effective catalysis of the Sonogashira cross-coupling reactions. Dalton Transactions 47(16): 5538-5541
Anonymous 1959: APPROVED residencies. Journal of the American Medical Association 171: 707-805
Shin, Y.; Moiseyev, G.; Petrukhin, K.; Cioffi, C.L.; Muthuraman, P.; Takahashi, Y.; Ma, J-Xing. 2018: A novel RPE65 inhibitor CU239 suppresses visual cycle and prevents retinal degeneration. Biochimica et Biophysica Acta. Molecular Basis of Disease 1864(7): 2420-2429
Zhao, L.; Wei, W.; Huang, Y.; Zhang, R.; Zhu, K.; Hao, D.; Su, Z.; Ma, G. 2018: A novel rProtein a chromatographic media for enhancing cleaning-in-place performance. Journal of Immunological Methods 460: 45-50
Anonymous 1952: APPROVED schools of occupational therapy. Archives of Physical Medicine and Rehabilitation 33(11): 651
Lefranc-Jullien, S.; Sunyach, C.; Checler, F.éd.ér. 2006: APPepsilon, the epsilon-secretase-derived N-terminal product of the beta-amyloid precursor protein, behaves as a type i protein and undergoes alpha-, beta-, and gamma-secretase cleavages. Journal of Neurochemistry 97(3): 807-817
Snyder, N.; Gajula, L.; Xiao, S.-Y.; Grady, J.; Luxon, B.; Lau, D.T.-Y.; Soloway, R.; Petersen, J. 2006: APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C. Journal of Clinical Gastroenterology 40(6): 535-542
Anonymous 2004: APRICOT Study evaluated. Surprisingly high virologic response in HIV-HCV coinfection. MMW Fortschritte der Medizin 146 Spec No 1: 74-75
Iłzecka, J.; Iłzecki, M. 2006: APRIL is increased in serum of patients with brain glioblastoma multiforme. European Cytokine Network 17(4): 276-280
Steven, K. 2004: APRN hospitalist: just a resident replacement?. Journal of Pediatric Health Care: Official Publication of National Association of Pediatric Nurse Associates and Practitioners 18(4): 208-210
McCloskey, B.; Grey, M.; Deshefy-Longhi, T.; Grey, L.J. 2003: APRN practice patterns in primary care. Nurse Practitioner 28(4): 39-44
Harbison, S. 2003: APRNs and multi-state licensure compacts. Journal of Pediatric Health Care: Official Publication of National Association of Pediatric Nurse Associates and Practitioners 17(6): 321-323
Rounds, L.R. 2005: APRNs in Texas. American Journal of Nursing 105(8): 15; Discussion 15
Gustafsson, J.; Alimohammadi, M.; Ekwall, O.; Gebre-Medhin, G.; Halldin-Stenlid, M.; Hedstrand, H.åk.; Landgren, E.; Nilsson, T.; Rorsman, F.; Sköldberg, F.; Winqvist, O.; Kämpe, O. 2004: APS I--a severe autoimmune disease with endocrine and non-endocrine symptoms. Lakartidningen 101(24): 2096-2098; 2101-2103
Gluskin, E. 1998: APS Insertion Devices: Recent Developments and Results. Journal of Synchrotron Radiation 5(Part 3): 189-195
Jozkowski, A.C.; Presgraves, E.A.; Hodges, K.L.; Wirth, E.N.; Brandstetter, N.E.; Thayer, M.T. 2018: A Novel Rubric to Evaluate Wearable Cameras for Assessment of Interrater Reliability. Otjr: Occupation Participation and Health 38(2): 121-130
Sastre-Garriga, J.; Montalban, X. 2003: APS and the brain. Lupus 12(12): 877-882
Hall, A.B.; Yassour, M.; Sauk, J.; Garner, A.; Jiang, X.; Arthur, T.; Lagoudas, G.K.; Vatanen, T.; Fornelos, N.; Wilson, R.; Bertha, M.; Cohen, M.; Garber, J.; Khalili, H.; Gevers, D.; Ananthakrishnan, A.N.; Kugathasan, S.; Lander, E.S.; Blainey, P.; Vlamakis, H.; Xavier, R.J.; Huttenhower, C. 2017: A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients. Genome Medicine 9(1): 103
Wan, R.; Xu, Q.; Han, M.; Ma, P.; Zhang, C.; Niu, J.; Wang, J. 2018: A Novel Ruthenium-Decorating Polyoxomolybdate Cs₃Na₆H[MoVI14RuIV₂O50(OH)₂]·24H₂O: An Active Heterogeneous Oxidation Catalyst for Alcohols. Materials 11(2)
Sullivan, M.; Terman, G.W.; Peck, B.; Correll, D.J.; Rich, B.; Clark, W.Crawford.; Latta, K.; Lebovits, A.; Gebhart, G. 2005: APS position statement on the use of placebos in pain management. journal of pain: official journal of the American Pain Society 6(4): 215-217
Kavanagh, D.; Hill, A.D.K.; Djikstra, B.; Kennelly, R.; McDermott, E.M.W.; O'Higgins, N.J. 2005: Adjuvant therapies in the treatment of stage Ii and IIi malignant melanoma. Surgeon: Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland 3(4): 245-256
Daly, J.M.; Jogerst, G.J.; Haigh, K.M.; Leeney, J.L.; Dawson, J.D. 2005: APS workers job requirements associated with elder abuse rates. Social Work in Health Care 40(3): 89-102
Fuad, S.; Doron, K.; Dror, K.; Hatoum, O.A. 2018: A novel safe approach to laparoscopic colorectal cancer resection in patients with ventriculoperitoneal shunt: report of two cases and literature review. Journal of Surgical Case Reports 2018(1): Rjx264
Chung, I.; Do, J.; Canlas, C.G.; Weliky, D.P.; Kanatzidis, M.G. 2004: APSe6 (A = K, Rb, and Cs): Polymeric selenophosphates with reversible phase-change properties. Inorganic Chemistry 43(9): 2762-2764
De Silva, R.J.; Vuylsteke, A.; Fritchley, S.J.; Trull, A.K.; Dunning, J.J.; Wallwork, J. 2006: APT070 inhibits complement activation during in vitro cardiopulmonary bypass. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 30(1): 72-76
Walensky, R.P. 2006: APTIMA assay approved for HIV testing. Aids Clinical Care 18(12): 109-110
Chernesky, M.A.; Jang, D.E. 2006: APTIMA transcription-mediated amplification assays for Chlamydia trachomatis and Neisseria gonorrhoeae. Expert Review of Molecular Diagnostics 6(4): 519-525
Zhao, L. 2002: APV--a new mode of mechanical ventilation. Zhongguo Yi Liao Qi Xie Za Zhi 26(4): 299-300
Jeffries, L.; Shima, H.; Ji, W.; Panisello-Manterola, D.; McGrath, J.; Bird, L.M.; Konstantino, M.; Narumi, S.; Lakhani, S. 2018: A novel SAMD9 mutation causing MIRAGE syndrome: An expansion and review of phenotype, dysmorphology, and natural history. American Journal of Medical Genetics. Part a 176(2): 415-420
Chen, X.; Dilks, K.J.; Huang, X.; Li, J. 2003: APdCu(Se2)(Se3) (A = K and Rb): new quaternary copper palladium polyselenides with unusual metal-selenium coordination. Inorganic Chemistry 42(12): 3723-3727
Griffenhagen, G. 2006: APhA Foundation history. Pharmacy in History 48(2): 69-90
Anonymous 2005: AQA releases ambulatory quality measures. Medicine and Health 59(16): 3-4
Anonymous 2006: AQA, HQA collaborate on national quality strategy. Healthcare Benchmarks and Quality Improvement 13(10): 115-117
Kalman, K.; Németh-Cahalan, K.L.; Froger, A.; Hall, J.E. 2006: AQP0-LTR of the Cat Fr mouse alters water permeability and calcium regulation of wild type AQP0. Biochimica et Biophysica Acta 1758(8): 1094-1099
Marchini, G.; Ståbi, B.; Kankes, K.; Lonne-Rahm, S.; Østergaard, M.; Nielsen, S.ør. 2003: AQP1 and AQP3, psoriasin, and nitric oxide synthases 1-3 are inflammatory mediators in erythema toxicum neonatorum. Pediatric Dermatology 20(5): 377-384
Skowronski, M.T.; Lebeck, J.; Rojek, A.; Praetorius, J.; Füchtbauer, E.-M.; Frøkiaer, J.ør.; Nielsen, S.ør. 2007: AQP7 is localized in capillaries of adipose tissue, cardiac and striated muscle: implications in glycerol metabolism. American Journal of Physiology. Renal Physiology 292(3): F956-F965
Gibiansky, E.; Struys, M.M.R.F.; Gibiansky, L.; Vanluchene, A.L.G.; Vornov, J.; Mortier, E.P.; Burak, E.; Van Bortel, L. 2005: AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase i dose-escalation comparison with DIPRIVAN (part 1): pharmacokinetics. Anesthesiology 103(4): 718-729
Struys, M.M.R.F.; Vanluchene, A.L.G.; Gibiansky, E.; Gibiansky, L.; Vornov, J.; Mortier, E.P.; Van Bortel, L. 2005: AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase i dose-escalation comparison with DIPRIVAN (part 2): pharmacodynamics and safety. Anesthesiology 103(4): 730-743
Asahina, H.; Ono, M.; Takahashi, K. 1961: AQuantitative determination of morphine in opium by means of official methods. Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 79: 107-109
Zacour, M. 1999: AR-C68397AA. AstraZeneca. Idrugs: the Investigational Drugs Journal 2(10): 1039-1044
Anonymous 2004: AR: Nurse injured while attending mandatory CE: comp. benefits denied on basis of 'inconsistencies'. Nursing law's Regan report 45(6): 3
Anonymous 2003: AR: RN has non-work-related back surgery: temporary total disability comp. benefits denied. Nursing Law's Regan Report 44(1): 3
Anonymous 2005: AR: RN injured back moving 300 lb. patient: claimant's right to benefits & physician of choice. Nursing Law's Regan Report 46(1): 3
Anonymous 2004: AR: Sedated colonoscopy pt. killed while driving: judgment for G.I. Center & nurse reversed. Nursing Law's Regan Report 45(4): 3
Anonymous 2004: AR: failure to follow protocol for no bowel sounds: nurse terminated for good cause denied UI benefit. Nursing Law's Regan Report 44(8): 3
Anonymous 2006: AR: failure to report work-related injury: workers' compensation benefits denied. Nursing Law's Regan Report 46(12): 3
Huda, H.; Sundaru, H.; Harsal, A.; Karyadi, T.H.; Prasetyo, S.B. 2005: Latex allergen sensitization due to glove use among hospital staff in Jakarta and related factors. Acta Medica Indonesiana 37(1): 3-11
Allison, J.T. 2005: ARAMARK takes Baylor's retail food program to new heights. ARAMARK Healthcare Management Services raises customer satisfaction and revenue levels for Baylor Health Care System through management of its retail food program. Healthcare Executive 20(3): 32-33
Krugmann, S.; Williams, R.; Stephens, L.; Hawkins, P.T. 2004: ARAP3 is a PI3K- and rap-regulated GAP for RhoA. Current Biology: Cb 14(15): 1380-1384
Barrios Alonso, V.; Escobar Cervantes, C.; Calderón Montero, A. 2005: ARB Ii in chronic heart failure. Coincidences and divergences. Class effect?. Revista Clinica Espanola 205(10): 499-506
Miura, S.-i. 2006: ARB for patients with hypertension. Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 6): 322-327
Vilar, F.áb.O.; de Araújo, L.A.P.; Lima, S.V.C. 2005: Total bladder replacement with de-epithelialized ileum. Experimental study in dogs. International Braz J Urol: Official Journal of the Brazilian Society of Urology 30(3): 237-244
Ludwig, W.; Strunk, O.; Westram, R.; Richter, L.; Meier, H.; Yadhukumar; Buchner, A.; Lai, T.; Steppi, S.; Jobb, G.; Förster, W.; Brettske, I.; Gerber, S.; Ginhart, A.W.; Gross, O.; Grumann, S.; Hermann, S.; Jost, R.; König, A.; Liss, T.; Lüssmann, R.; May, M.; Nonhoff, B.ör.; Reichel, B.; Strehlow, R.; Stamatakis, A.; Stuckmann, N.; Vilbig, A.; Lenke, M.; Ludwig, T.; Bode, A.; Schleifer, K.-H. 2004: ARB: a software environment for sequence data. Nucleic Acids Research 32(4): 1363-1371
Holzmann, P. 1982: ARBAN-A new method for analysis of ergonomic effort. Applied Ergonomics 13(2): 82-86
Lenz, R.; Buessecker, F.; Herlofsen, H.; Hinrichs, F.; Zeiler, T.; Kuhn, K.A. 2005: Demand-driven evolution of IT systems in healthcare--a case study for improving interdisciplinary processes. Methods of Information in Medicine 44(1): 4-10
Anonymous 2005: ARBs and Myocardial Infarction. Medical Letter on Drugs and Therapeutics 47(1208): 38-39
Opie, L.H. 2005: ARBs and mortality in myocardial infarction. Cardiovascular Journal of South Africa: Official Journal for Southern Africa Cardiac Society and South African Society of Cardiac Practitioners 16(2): 84
Silverstein, R.L.; Fenves, A.Z.; Ram, C.V.S. 2004: ARBs and target organ protection. Exploring benefits beyond their antihypertensive effects. Postgraduate Medicine 116(2): 31-38; 41
Ishigami, T.; Uchino, K.; Umemura, S. 2006: ARBs or ACEIs, that is the question. Hypertension Research: Official Journal of the Japanese Society of Hypertension 29(11): 837-838
Anonymous 2003: ARBs reduce heart-failure deaths, hospitalizations. Health News 9(11): 6
Greenwood, V. 2005: ARBs vs ACE inhibitors for preventing diabetic nephropathy. Journal of Family Practice 54(5): 453; Discussion 453-4
Laforgia, N.; Burattini, M.G.; Giannuzzo, S.; Storelli, S.; Mautone, A. 2005: ARC syndrome. Acta Paediatrica 94(2): 254-255
Meng, F.; Nguyen, X-Thao.; Cai, X.; Duan, J.; Matteucci, M.; Hart, C.P. 2007: ARC-111 inhibits hypoxia-mediated hypoxia-inducible factor-1alpha accumulation. Anti-Cancer Drugs 18(4): 435-445
Zizka, Z.; Hostounský, Z.; Gabriel, J. 2003: ARC-microscopy--a novel microscopic technique used in microbiological studies. Folia Microbiologica 48(6): 829-838
Osorio, V.; Schriks, M.; Vughs, D.; de Voogt, P.; Kolkman, A. 2018: A novel sample preparation procedure for effect-directed analysis of micro-contaminants of emerging concern in surface waters. Talanta 186: 527-537
Lawler, A. 2003: ARCHAEOLOGY: Good and Bad News From Iraq. Science 301(5641): 1825
Myrmel, H.; Navaratnam, V.; Asjø, B. 2005: ARCHITECT anti-HCV assay. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 34(4): 317
Anonymous 1952: ARCHIVES for a history of medicine in South Africa. South African Medical Journal 26(2): 30
Van Riebeeck, J. 1952: ARCHIVES for a history of medicine in South Africa; Van Riebeeckana and related matters. South African Medical Journal 26(14): 281-292
Anonymous 1953: ARCHIVES of the College and its predecessor the Company of Surgeons. Annals of the Royal College of Surgeons of England 12(4): 282-285
Watson, M.J.; Holt, J.D.S.; O'Neill, S.J.; Wei, K.; Pendergast, W.; Gross, G.J.; Gengo, P.J.; Chang, K.-J. 2006: ARD-353 [4-((2R,5S)-4-(R)-(4-diethylcarbamoylphenyl)(3-hydroxyphenyl)methyl)-2,5-dimethylpiperazin-1-ylmethyl)benzoic acid], a novel nonpeptide delta receptor agonist, reduces myocardial infarct size without central effects. Journal of Pharmacology and Experimental Therapeutics 316(1): 423-430
Prosst, R.L.; Majetschak, M. 2005: ARDS after unreamed femoral nailing. Der Unfallchirurg 108(4): 332-336
Castro, C.Y. 2006: ARDS and diffuse alveolar damage: a pathologist's perspective. Seminars in Thoracic and Cardiovascular Surgery 18(1): 13-19
Lyons, W.S. 2005: ARDS and nosocomial pneumonia: scientific value of parenteral fluids data. Chest 127(2): 682; Author Reply 682-3
Pandey, D.; Sharma, B.; Chauhan, V.; Mokta, J.; Verma, B.S.; Thakur, S. 2006: ARDS complicating scrub typhus in Sub-Himalayan region. Journal of the Association of Physicians of India 54: 812-813
Taylor, M.M. 2005: ARDS diagnosis and management: implications for the critical care nurse. Dimensions of Critical Care Nursing: Dccn 24(5): 197-207; Quiz: 208-209
Salto-Tellez, M.; Tan, E.; Lim, B. 2005: ARDS in SARS: cytokine mediators and treatment implications. Cytokine 29(2): 92-94
Malye, R.H.; Trivedi, T.H.; Padhiyar, N.N.; Moulick, N.D.; Yeolekar, M.E. 2004: ARDS in a case of vesicular mole with secondary hyperthyroidism. Journal of the Association of Physicians of India 52: 992-993
Lu, Z.-j.; Wang, Y.; Tang, D.-h.; Mi, Y.-q.; Sun, B. 2003: ARDS in children: a prospective clinical study in four children's hospitals in Shanghai. Zhonghua Er Ke Za Zhi 41(8): 619-620
Flabouris, A.; Schoettker, P.; Garner, A. 2003: ARDS with severe hypoxia--aeromedical transportation during prone ventilation. Anaesthesia and Intensive Care 31(6): 675-678
Hammer, J.ür. 2006: ARDS--long term follow up. Paediatric Respiratory Reviews 7(Suppl 1): S192-S193
Lapinsky, S.E.; Mehta, S. 2007: ARDS--shake, rattle, and roll!. Critical Care Medicine 35(1): 303-304
Udwadia, Z.F. 2003: ARDS: predicting mortality and improving survival. Journal of the Association of Physicians of India 51: 849-850
Bilton, R.; Trottier, E.; Pouysségur, J.; Brahimi-Horn, M.C. 2006: ARDent about acetylation and deacetylation in hypoxia signalling. Trends in Cell Biology 16(12): 616-621
Anonymous 1957: ARE HOSPITALS liable for their employee's negligence?. American Journal of Nursing 57(7): 875-877
Anonymous 1958: ARE MICROWAVES dangerous?. British Medical Journal 2(5103): 1030
Anonymous 1958: ARE THERE too many doctors in Canada. Canadian Medical Association Journal 78(12): 966-968
Anonymous 1957: ARE YOU making the most of rehabilitation?. Wisconsin Medical Journal 56(1): 64-65
Boehm, D.; Letourneau, C.U. 1956: The growing influence of hospital accreditation. I. the professions and professional education. Hospital Management 82(4): 48-49 Passim
Anonymous 1958: ARE YOUR patients fit to drive. Connecticut State Medical Journal 22(5): 391-392
Anonymous 1952: ARE the V leads always superior?. Annals of Internal Medicine 36(6): 1548-1552
Sister B Bezaire 1952: The heart of the matter. Canadian Hospital 29(12): 33-35
Richardson, W.A. 1950: AMA elects new leaders, new projects. Medical Economics 27(11): 52-59 Passim
Emmett, J.; Siverly, R.E. 1951: Human myiasis from the screwworm fly in Arizona. Arizona Medicine 8(9): 57-60
Goodrich, D.W. 1954: The present status of research in occupational therapy. American Journal of Occupational Therapy: Official Publication of the American Occupational Therapy Association 8(4): 142-143 Passim
Gaynes, B.I. 2003: AREDS misses on safety. Archives of Ophthalmology 121(3): 416-417
Jampol, L.M. 2003: AREDS--two years later. Archives of Ophthalmology 121(11): 1634-1636
Randone, M.; Aretaeus, A.DE.CAPPADOCIA. 1963: ARETAEUS of Cappadocia, the earliest phthisiologist. Minerva Medica 54: Varia: 358-360
Thakar, C.V.; Liangos, O.; Yared, J.-P.; Nelson, D.; Piedmonte, M.R.; Hariachar, S.; Paganini, E.P. 2003: ARF after open-heart surgery: Influence of gender and race. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 41(4): 742-751
Chiu, Y.Shin.; Chiang, H.Wei.; Huang, C.Yuan.; Tsai, T.Jun. 2003: ARF after retrograde pyelography: a case report and literature review. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 42(2): E13-E16
Aydin, Z.; Bruijn, J.A.; Vleming, L.-J. 2004: ARF and cerebral infarcts in a young woman. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 44(1): 179-183
Hill, P.A.; Barit, D.; Toussaint, N. 2005: ARF in 2 patients with long-standing type 2 diabetes mellitus. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 45(2): 429-434
Vande Walle, J.; Mauel, R.; Raes, A.; Vandekerckhove, K.; Donckerwolcke, R. 2004: ARF in children with minimal change nephrotic syndrome may be related to functional changes of the glomerular basal membrane. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 43(3): 399-404
Choi, Y.H.; Kim, N.; Seo, Y.S.; Choi, S.J.; Yang, J.O.; Lee, E.-Y.; Hong, S.Y.; Lee, H.S. 2003: ARF requiring hemodialysis after accidental perchloroethylene ingestion. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 41(3): E11
Rocha, S.; Perkins, N.D. 2005: ARF the integrator: linking NF-kappaB, p53 and checkpoint kinases. Cell Cycle 4(6): 756-759
Bonsib, S.M.; Bergstein, J. 2004: ARF with casts eliciting a cellular reaction. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 43(6): 1138-1141
Ferl, R.J. 1990: ARF-B(2): a Protein Complex that Specifically Binds to Part of the Anaerobic Response Element of Maize Adh 1. Plant Physiology 93(3): 1094-1101
Aikawa, Y.; Martin, T.F.J. 2003: ARF6 regulates a plasma membrane pool of phosphatidylinositol(4,5)bisphosphate required for regulated exocytosis. Journal of Cell Biology 162(4): 647-659
Casanova, J.E. 2003: ARFs. Current Biology: Cb 13(4): R123
Anonymous 1960: ARGENTAFFINOMA and bronchial adenoma. Lancet 2(7146): 355-356
Anonymous 1953: ARGONNE Cancer Research Hospital. New England Journal of Medicine 248(23): 991-992
Dubois, T.; Chavrier, P. 2005: ARHGAP10, a novel RhoGAP at the cross-road between ARF1 and Cdc42 pathways, regulates Arp2/3 complex and actin dynamics on Golgi membranes. Medecine Sciences: M/S 21(8-9): 692-694
Katoh, M.; Katoh, M. 2005: ARHGAP20 gene at 11q22.3-q23.1 oncogenomic recombination hot spot. Genes Chromosomes and Cancer 44(1): 109-10; Author Reply 111-2
Lu, Z.H.; Chen, J.; Gu, L.J.; Luo, Y.F.; Gu, C.F. 2001: ARHi mRNA and protein expression in pancreatic cancers. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 23(4): 324-327
Frick, M.; Hofmann, T.; Haupt, C.; Schmidt, C. 2018: A novel sample preparation strategy for shotgun lipidomics of phospholipids employing multilamellar vesicles. Analytical and Bioanalytical Chemistry 410(18): 4253-4258
Murakami, K.; Saito, M.; Takuma, E.; Ichinose, H. 2003: ARHVTEM of the Pd/ZnO heterointerface chemical structure. Journal of Electron Microscopy 52(1): 27-32
Qiu, X.; Fay, D.S. 2006: ARI-1, an RBR family ubiquitin-ligase, functions with UBC-18 to regulate pharyngeal development in C. elegans. Developmental Biology 291(2): 239-252
Mavale-Manuel, S.; Alexandre, F.; Duarte, N.; Albuquerque, O.; Scheinmann, P.; Poisson-Salomon, A.S.; de Blic, J. 2004: Risk factors for asthma among children in Maputo (Mozambique). Allergy 59(4): 388-393
Passalacqua, G.; Bousquet, P.J.; Carlsen, K-Hakon.; Kemp, J.; Lockey, R.F.; Niggemann, B.; Pawankar, R.; Price, D.; Bousquet, J. 2006: ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthma. Journal of Allergy and Clinical Immunology 117(5): 1054-1062
Plavec, D. 2004: ARIA--one airway, one disease: what links our research to the concept?. Arhiv Za Higijenu Rada i Toksikologiju 55(2-3): 135-140
Anonymous 1959: ARIZONA Poisoning Control Center. Arizona Medicine 16(5): 388-389
Anonymous 1958: ARIZONA Poisoning Control Information Center. Arizona Medicine 15(2): 128-129
Negovskii, V.A. 1953: Role of the higher centers of the brain in extinction and in restoration of vital functions of the organism. Arkhiv Patologii 15(4): 3-14
Anonymous 1959: ARKANSAS public health at a glance selected causes of childhood mortality (0-19yrs.) Arkansas 1955-1957. Journal of the Arkansas Medical Society 56(2): 89
Jeffries, J. 2003: ARLNA in the 1930s: the stars beckon onwards. Journal of Ahima 74(2): 58-61
De Llano Temboury, A.Q.; Arévalo, R.L.óp.; Queipo de Lllano Jiménez, F.L.G.ál.y.E. 2006: ARM: a modular hinged joint for the AO tubular external fixator. Techniques in Hand and Upper Extremity Surgery 10(1): 14-24
Utley, M.; Gallivan, S.; Biddulph, J.; McCarthy, M.; Ferguson, J. 2003: ARMADA--a computer model of the impact of environmental factors on health. Health Care Management Science 6(3): 137-146
Anonymous 1959: ARMCHAIR and anticoagulants for cardiac infarction. Lancet 1(7069): 401
Anonymous 1952: ARMED Forces Medical Library. United States Armed Forces Medical Journal 3(6): 830
Simpson, W.M. 1953: Brucellosis; advances in therapy. United States Armed Forces Medical Journal 4(3): 337-349
Anonymous 1953: ARMED Forces Medical Policy Council. IV. Civil and Military Interrelations Division. United States Armed Forces Medical Journal 4(5): 641-642
Yoss, R.E. 1950: Vascular supply of the spinal cord: the production of vascular syndromes. Medical Bulletin 16(11): 333-345
Marmion, B.P. 1953: World-wide Q fever. Lancet 265(6786): 616-617
Anonymous 1953: ARMED forces. British Medical Journal 2(4834): 503-504
Anonymous 1953: ARMED forces faced with surplus of medical officers. Journal of the American Medical Association 153(1): 34
Anonymous 1952: ARMED services: failure to use draftee as physician. Journal of the American Medical Association 150(8): 815-816
Anonymous 1950: ARMOUR insufflator accepted. Journal of the American Medical Association 143(12): 1069
Miller, G.A.; Frick, F.C. 1949: Statistical behavioristics and sequences of responses. Psychological Review 56(6): 311-324
Fordham, C.C. 1956: Acute hemolytic anemia complicating infectious mononucleosis. United States Armed Forces Medical Journal 7(1): 98-100
Scheele, L.A. 1956: The distribution of poliomyelitis vaccine and its efficacy in 1955. Journal of the National Medical Association 48(5): 363-364
Anonymous 1958: ARMY MEDICAL services in Middle East and Far East campaigns. Medical Journal of Australia 45(5): 170-171
Scott, N.M. 1951: The treatment of Friedlander's pneumonia. Medical Bulletin. United States. Army. European Command. Medical Division 8(8): 367-370
Diamond, E.F. 1959: Systolic murmur in childhood. Medical Times 87(3): 321-322
Lindemayr, W. 1954: Etiological problems in chronic urticaria. I. the role of the gastrointestinal tract. Dermatologische Wochenschrift 130(51): 1343-1352
Anonymous 1952: ARMY begins construction of first of seven hospitals to replace cantonments. Modern Hospital 79(3): 174-176
Tadros, W. 1950: Hormonal imbalance in cancer; a survey and new aspects; chemical and biochemical aspects. Journal of the Egyptian Medical Association 33(3): 251-266
Anonymous 1952: ARMY giving primaquine treatment to all returning servicemen. Public Health Reports 67(2): 178-179
Young, E.J. 1952: The meaning of the thyroid nodule. Medical Bulletin. United States. Army. European Command. Medical Division 9(1): 9-13
Guess, J.D. 1952: Our Blue Shield fee schedule. Journal of the South Carolina Medical Association 48(11): 307-308
Anonymous 1951: ARMY medical officer. British Medical Journal 2(4729): 489-490
Nelson, R.S. 1952: Gastroscopy as a routine diagnostic procedure. Medical Bulletin of the U. S. Army Europe. United States. Army Europe. Medical Division 9(5): 199-204
Anonymous 1951: ARMY nurse recruitment-state quotas. American Journal of Nursing 51(2): 93
Anonymous 1950: ARMY tests new x-ray machine. Military Surgeon 106(6): 483
Wright, D. 1951: The exposure treatment of burns. Medical Bulletin. United States. Army. European Command. Medical Division 8(12): 531-533
Mahoney, F.I. 1953: Opportunities for women in medicine; physical rehabilitation. Journal of the American Medical Women's Association 8(3): 107-109
Hernández-Deviez, D.J.; Roth, M.G.; Casanova, J.E.; Wilson, J.M. 2004: ARNO and ARF6 regulate axonal elongation and branching through downstream activation of phosphatidylinositol 4-phosphate 5-kinase alpha. Molecular Biology of the Cell 15(1): 111-120
Anonymous 1952: ARNOLD Loewenstein M.D. Prague. Lancet 2(6745): 1138
Keaton, R. 2002: ARNP licensure in Florida. Florida Nurse 50(4): 13
Rowatt, A.J.; DePowell, J.J.; Powell, W.H. 2003: ARNT gene multiplicity in amphibians: characterization of ARNT2 from the frog Xenopus laevis. Journal of Experimental Zoology. Part B Molecular and Developmental Evolution 300(1): 48-57
Morris, R.J.; Perrakis, A.; Lamzin, V.S. 2003: ARP/wARP and automatic interpretation of protein electron density maps. Methods in Enzymology 374: 229-244
Carew, J.A.; Jackson, A.A.; Bauer, K.A. 2003: ARP1 interacts with the 5' flanking region of the coagulation factor VIi gene. Journal of Thrombosis and Haemostasis: Jth 1(6): 1220-1227
Heimsath, E.G.; Unda, R.; Vidro, E.; Muniz, A.; Villazana-Espinoza, E.T.; Tsin, A. 2006: ARPE-19 cell growth and cell functions in euglycemic culture media. Current Eye Research 31(12): 1073-1080
Yang, H.-B.; Wang, S.-C.; Sekharan, A.K.P.; Matsui, H.; Souma, S.; Sato, T.; Takahashi, T.; Takeuchi, T.; Campuzano, J.C.; Jin, R.; Sales, B.C.; Mandrus, D.; Wang, Z.; Ding, H. 2004: ARPES on Na0.6CoO2: Fermi surface and unusual band dispersion. Physical Review Letters 92(24): 246403
Anonymous 1952: ARRANGING the treatment room. American Journal of Nursing 52(4): 444
Reid, J. 2005: ARRT gender comparison. Radiologic Technology 77(2): 143-146
Ebeler, S.E.; Dingley, K.H.; Ubick, E.; Abel, S.; Mitchell, A.E.; Burns, S.A.; Steinberg, F.M.; Clifford, A.J. 2005: Animal models and analytical approaches for understanding the relationships between wine and cancer. Drugs Under Experimental and Clinical Research 31(1): 19-27
Mastrangeli, R.; Donini, S.; Kelton, C.A.; He, C.; Bressan, A.; Milazzo, F.; Ciolli, V.; Borrelli, F.; Martelli, F.; Biffoni, M.; Serlupi-Crescenzi, O.; Serani, S.; Micangeli, E.; El Tayar, N.; Vaccaro, R.; Renda, T.; Lisciani, R.; Rossi, M.; Papoian, R. 2003: ARS Component B: structural characterization, tissue expression and regulation of the gene and protein (SLURP-1) associated with Mal de Meleda. European Journal of Dermatology: Ejd 13(6): 560-570
Gomez, C.M. 2004: ARSACS goes global. Neurology 62(1): 10-11
Anonymous 1959: ARSENIC again. Lancet 1(7075): 721
Anonymous 1960: ARSENIC in cigarettes. British Medical Journal 1(5166): 118-119
Anonymous 1956: ARSENICALS as growth promoters. Nutrition Reviews 14(7): 206-209
Carter, M. 2003: ART and liver-related mortality in HIV/HCV. Iapac Monthly 9(12): 315
Highleyman, L. 2004: ART effective in prisoners, benefit lost upon release. Iapac Monthly 10(6): 191-192
Elster, N.R. 2005: ART for the masses? Racial and ethnic inequality in assisted reproductive technologies. Depaul Journal of Health Care Law 9(1): 719-733
Agostini, L.; Castorina, G. 1953: Behavior of the vestibulo-oculomotor reflex under thermal stimulation in temporal lobe tumors. Rivista di Neurologia 22(5): 694-700
van den Dungen, G.M.; Huddleston Slater, A.E.; van Amerongen, W.E. 2004: ART or conventional restorations? A final evaluation of proximal restorations in deciduous molars. Nederlands Tijdschrift Voor Tandheelkunde 111(9): 345-349
Frencken, J.E.; Holmgren, C.J. 2004: ART: a minimal intervention approach to manage dental caries. Dental Update 31(5): 295-298; 301
Verberg, M.F.G.; Macklon, N.S.; Heijnen, E.M.E.W.; Fauser, B.C.J.M. 2007: ART: iatrogenic multiple pregnancy?. Best Practice and Research. Clinical Obstetrics and Gynaecology 21(1): 129-143
Boniface, M.; Wilken, P. 2005: ARTEMIS: towards a secure interoperability infrastructure for healthcare information systems. Studies in Health Technology and Informatics 112: 181-189
Anonymous 1951: ARTERIAL grafts. Lancet 2(6692): 1025-1026
Anonymous 1952: ARTERIOSCLEROSIS in the golden hamster. Nutrition Reviews 10(5): 148-149
Anonymous 1959: ARTERIOSCLEROSIS in zoo animals. Nutrition Reviews 17(6): 173-174
Anonymous 1955: ARTERIOSCLEROSIS studies. Public Health Reports 70(3): 299-303
Hall, T.N. 1952: The use of ACTH and cortisone in the treatment of rheumatic carditis in children. Nebraska State Medical Journal 37(2): 31-34
Anonymous 1952: ARTERIOVENOUS fistula in the neck. Journal of Pediatrics 40(5): 661-667
Anonymous 1952: ARTERIOVENOUS pulmonary fistula. Journal of the American Medical Association 148(2): 123
Anonymous 1959: ARTHRITIS and ulcerative colitis. Lancet 2(7102): 554
Anonymous 1958: ARTHRITIS in ulcerative colitis. British Medical Journal 2(5094): 500
Gilbert, S.M. 1956: Medical aspects of nonspecific ulcerative colitis. Journal of the Medical Society of new Jersey 53(9): 447-449
Anonymous 1956: ARTHRITIS, polymyositis and polyneuritis. American Journal of Medicine 20(3): 462-473
Sexton, G.B. 1950: Modern treatment of neurosyphilis. Canadian Medical Association Journal 62(1): 43-47
Anonymous 1959: ARTHROPOD-BORNE viruses. Lancet 1(7066): 240-242
Appleton, A.B. 1950: ARTHUR B Appleton. British Medical Journal 1(4661): 1083-1084
Welton, T.S. 1953: Twenty-five years. American Journal of Surgery 85(1): 1-3
Scott, A.C. 1956: ARTHUR C. SCOTT, Jr. Texas State Journal of Medicine 52(4): 268-269
Bachmeyer, A.CHARLES. 1953: ARTHUR Charles Bachmeyer. Journal of the American Medical Association 152(10): 952
Snowden, A.DE.WINTON. 1950: ARTHUR De Winton Snowden. Lancet 1(6617): 1176
Atkins, H.J.B. 1952: Pain in the breast. Lancet 1(6702): 271-274
Evans, A.GEOFFREY. 1951: ARTHUR Geoffrey Evans. Lancet 2(6680): 453-454
Spicer, A.H. 1951: ARTHUR Herbert Spicer. Guy's Hospital Gazette 65(1645): 288
Hall, A.J. 1951: ARTHUR John Hall. Lancet 1(6646): 116-117
Stone, A.KINGSBURY. 1952: ARTHUR Kingsbury Stone, 1861-1952. New England Journal of Medicine 247(17): 656-657
Davidson, A.M. 1955: ARTHUR Madgwick Davidson. Medical Journal of Australia 42(1 14): 517-519
Anonymous 1951: ARTHUR Stanley Institute for Treatment of Rheumatism. Nursing Times 47(16): 394-395
Bankart, A.S.B. 1951: ARTHUR Sydney Blundell Bankart. Lancet 1(6660): 915
Grant, R.L.T.; Black, G.H.B. 1956: Geoffrey Howard Barham Black. Medical Journal of Australia 43(10): 426-427
Anonymous 1952: ARTIFICIAL circulation. British Medical Journal 2(4794): 1141-1142
Anonymous 1951: ARTIFICIAL enrichment of white rice in the Philippines. Nutrition Reviews 9(7): 218-219
Anonymous 1958: ARTIFICIAL feeding among the Baganda. Nutrition Reviews 16(8): 238-239
Russell, C.S. 1953: Leucorrhoea. British Medical Journal 2(4827): 91-93
Wan, T.H.; Jen, C.Y.; Shih, M.H. 1959: Primary tumors and cysts of mediastinum. Chinese Medical Journal 78(5): 424-434
Anonymous 1957: ARTIFICIAL insemination. Journal of the American Medical Association 165(4): 367-369
Timakov, V.D. 1953: Problem of variability of pathogenic micro-organisms. Sovetskaia Meditsina 17(4): 3-7
Kaufmann, J.W. 1952: Inventory and purchasing system for the medium-sized hospital. Hospitals 26(7): 89-90
Anonymous 1955: ARTIFICIAL respiration and carbon dioxide. British Medical Journal 1(4911): 468-469
Anonymous 1955: ARTIFICIAL respiration by intermittent positive pressure. Lancet 269(6880): 79
Anonymous 1957: ARTIFICIAL respiration technic for infants and small children. United States Armed Forces Medical Journal 8(6): 851-854
Tong, E.K.; Glantz, S.A. 2004: ARTIST (Asian regional tobacco industry scientist team): Philip Morris' attempt to exert a scientific and regulatory agenda on Asia. Tobacco Control 13 Suppl. 2: Ii118-Ii124
Parsons, O.; Carpenter, G.A. 2003: ARTMAP neural networks for information fusion and data mining: map production and target recognition methodologies. Neural Networks: the Official Journal of the International Neural Network Society 16(7): 1075-1089
Carpenter, G.A.; Markuzon, N. 1998: ARTMAP-IC and medical diagnosis: Instance counting and inconsistent cases. Neural Networks: the Official Journal of the International Neural Network Society 11(2): 323-336
Clayden, P. 2005: ARV birth defect risks. Gmhc Treatment Issues: the Gay Men's Health Crisis Newsletter of Experimental Aids Therapies 19(12): 10
Bateman, C. 2004: ARV compliance--the new battle terrain. South African Medical Journal 94(8): 602
Huff, B. 2003: ARV in Sub-Saharan Africa: 17 reports. Gmhc Treatment Issues: the Gay Men's Health Crisis Newsletter of Experimental Aids Therapies 17(7-8): 4-6
Sharma, D.C. 2003: ARV prices nosedive after Clinton brokering. Lancet 362(9394): 1467
Bateman, C. 2004: ARV roll-out--the quick and the dead. South African Medical Journal 94(5): 322-323
Thouet, T.; Krueger, J.J.; Paetsch, I.; Kelle, S.; Nagel, E. 2006: ARVC with left ventricular involvement in a young woman. European Heart Journal 27(21): 2510
Wolfe, B.A.; Corwin, E.J. 2005: ARVD: a silent killer. Nurse Practitioner 30(5): 16-18; 23-27; Quiz: 27-29
Admire, A.; Shanks, L.; Danzl, N.; Wang, M.; Weier, U.; Stevens, W.; Hunt, E.; Weinert, T. 2006: Cycles of chromosome instability are associated with a fragile site and are increased by defects in DNA replication and checkpoint controls in yeast. Genes and Development 20(2): 159-173
Van Esch, H.; Poirier, K.; de Zegher, F.; Holvoet, M.; Bienvenu, T.; Chelly, J.; Devriendt, K.; Fryns, J.-P. 2004: ARX mutation in a boy with transsphenoidal encephalocele and hypopituitarism. Clinical Genetics 65(6): 503-505
Gécz, J.; Cloosterman, D.; Partington, M. 2006: ARX: a gene for all seasons. Current Opinion in Genetics and Development 16(3): 308-316
Vallejo De Simon, A.M. 1953: Therapy of tuberculous meningitis at the Hospital del Rey; current status of therapy of the disease. Medicina 21(1: 5): 250-276
Anonymous 1956: AS THE patient sees it. Medical World 85(3): 279-283
Wyngaarden, J.B.; Seevers, M.H. 1951: The toxic effects of antihistaminic drugs. Journal of the American Medical Association 145(5): 277-282
Anonymous 1952: AS a patient saw it. Lancet 2(6724): 75
Thompson, M.J. 1953: A standardized indirect technic for reversible hydrocolloid. Journal of the American Dental Association 46(1): 1-18
Treebak, J.T.; Birk, J.B.; Rose, A.J.; Kiens, B.; Richter, E.A.; Wojtaszewski, J.ør.F.P. 2007: AS160 phosphorylation is associated with activation of alpha2beta2gamma1- but not alpha2beta2gamma3-AMPK trimeric complex in skeletal muscle during exercise in humans. American Journal of Physiology. Endocrinology and Metabolism 292(3): E715-E722
Carboni, S.; Hiver, A.; Szyndralewiez, C.; Gaillard, P.; Gotteland, J.-P.; Vitte, P.-A. 2004: AS601245 (1,3-benzothiazol-2-yl (2-[[2-(3-pyridinyl) ethyl] amino]-4 pyrimidinyl) acetonitrile): a c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties. Journal of Pharmacology and Experimental Therapeutics 310(1): 25-32
Anonymous 2005: ASA advisory on anesthesia awareness. OR manager 21(12): 5
Praetorius, M.; Staecker, H. 2006: ASA and the inner ear. An old acquaintance in a new light. Hno 54(9): 667-669
Ross, B.K. 2003: ASA closed claims in obstetrics: lessons learned. Anesthesiology Clinics of North America 21(1): 183-197
Ruiz De Temino, P. 1952: Facial neuralgias. Odontoiatria; Revista Ibero-Americana de Medicina de la Boca 9(106): 513-528
Golubović, V.; Golubović, S. 2002: ASA score as prognostic criterion for incidence of postoperative complications after transhiatal esophagectomy. Collegium Antropologicum 26 Suppl: 149-153
Fishman, M. 2004: ASA, NSAIDs, coxibs and colorectal cancer prevention--how far have we come?. Canadian Journal of Gastroenterology 18(7): 467-8; Discussion 468
Zanow, F.; Knösche, T.R. 2004: ASA--Advanced Source Analysis of continuous and event-related EEG/MEG signals. Brain Topography 16(4): 287-290
Murphy, D. 2003: ASAE's Ergonomics, Safety, and Health Division--cosmetics or real progress?. Journal of Agricultural Safety and Health 9(4): 263-264
Liebson, P.R. 2003: ASAP and ANTIBIO. Preventive Cardiology 6(3): 166-168
Dhingra, A.; Folta, K.M. 2005: ASAP: amplification, sequencing & annotation of plastomes. Bmc Genomics 6: 176
Lunn, J.; Lee, R.; Martin, P.; Malik, R. 2003: Antemortem diagnosis of canine neural angiostrongylosis using ELISA. Australian Veterinary Journal 81(3): 128-131
Morfin, I.; Ehrburger-Dolle, F.ço.; Grillo, I.; Livet, F.éd.ér.; Bley, F.ço. 2006: ASAXS, SAXS and SANS investigations of vulcanized elastomers filled with carbon black. Journal of Synchrotron Radiation 13(Part 6): 445-452
Anonymous 2004: ASB for the future of nursing in Germany. KrankenpflegeJournal 42(5-6): 150
Voon, V. 2004: Repetition, repetition, and repetition: compulsive and punding behaviors in Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society 19(4): 367-370
Jones, R.B.; Anasetti, C.; Appel, P.; DiPersio, J.; Heslop, H.; Lemaistre, F.; Silver, S.; Sirilla, J.; Stiff, P. 2006: ASBMT committee report: white paper on measurement of quality outcomes. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 12(5): 594-597
Sagara, J. 2006: ASC and PYRIN family: novel players regulating innate immunity and apoptosis. Seikagaku. Journal of Japanese Biochemical Society 78(6): 483-491
Sarkar, A.; Duncan, M.; Hart, J.; Hertlein, E.; Guttridge, D.C.; Wewers, M.D. 2006: ASC directs NF-kappaB activation by regulating receptor interacting protein-2 (RIP2) caspase-1 interactions. Journal of Immunology 176(8): 4979-4986
Masumoto, J.; Dowds, T.A.; Schaner, P.; Chen, F.F.; Ogura, Y.; Li, M.; Zhu, L.; Katsuyama, T.; Sagara, J.; Taniguchi, S.'i.; Gumucio, D.L.; Núñez, G.; Inohara, N. 2003: ASC is an activating adaptor for NF-kappa B and caspase-8-dependent apoptosis. Biochemical and Biophysical Research Communications 303(1): 69-73
Flowers, L. 2006: ASC leaders see bigger salary increases. Or Manager 22(10): 29-31
Mitchell, A.B.; Tang, B.; Shojaei, M.; Barnes, L.S.; Nalos, M.; Oliver, B.G.; McLean, A.S. 2018: A novel sampling method to detect airborne influenza and other respiratory viruses in mechanically ventilated patients: a feasibility study. Annals of Intensive Care 8(1): 45
Flowers, L. 2005: ASC managers earn less but more satisfied. Or Manager 21(10): 36; 38, 40
Fernsebner, B.; Flowers, L. 2004: ASC managers juggle competing demands. Or Manager 20(10): 33-34; 37
Flowers, L. 2006: ASC safety begins with patient selection. Or Manager 22(4): 25-27
Chivukula, M.; Shidham, V.B. 2006: ASC-H in Pap test--definitive categorization of cytomorphological spectrum. Cytojournal 3: 14
Choma, K.K. 2003: ASC-US and HPV testing. American Journal of Nursing 103(2): 42-50; 51 Quiz
Hasegawa, M.; Imamura, R.; Kinoshita, T.; Matsumoto, N.; Masumoto, J.; Inohara, N.; Suda, T. 2005: ASC-mediated NF-kappaB activation leading to interleukin-8 production requires caspase-8 and is inhibited by CLARP. Journal of Biological Chemistry 280(15): 15122-15130
Wilson, D.J.; Haynes, J.K. 2002: ASCB Minorities Affairs Committee goals: "strengthening the chain of success". Cell Biology Education 1(4): 105-106
Haefner, H.; Ansbacher, R. 2004: ASCCP 2004 Distinguished Scientific Achievement Award given to Raymond H. Kaufman, MD. Journal of lower genital tract disease 8(3): 179-180
Davey, D.D.; Austin, R.Marshall.; Birdsong, G.; Buck, H.W.; Cox, J.Thomas.; Darragh, T.M.; Elgert, P.A.; Hanson, V.; Henry, M.R.; Waldman, J. 2002: ASCCP Patient Management Guidelines: Pap Test Specimen Adequacy and Quality Indicators. Journal of Lower Genital Tract Disease 6(3): 195-199
Wilkinson, E.J. 2002: ASCCP President's Report. Journal of lower genital tract disease 6(1): 57-60
Kaushansky, K. 2004: ASCI Presidential Address: Mentoring and teaching clinical investigation. Journal of clinical investigation 114(8): 1165-1168
Anonymous 1960: ASCITES in the liver disease. British Medical Journal 2(5204): 1002-1003
Dobney, G.H. 1951: Work on the land; its potentialities for resettlement of the disabled. Lancet 2(6681): 492-494
Klein, G.; Klein, E. 1956: Conversion of solid neoplasms into ascites tumors. Annals of the new York Academy of Sciences 63(5): 640-661
Anonymous 1960: ASCLEPIUS--man or myth. Journal of the American Medical Association 172: 245-246
Muhsin, M.; Nitsche, F. 2000: ASCO - 36th Meeting. Media sessions and integrated symposia. IDrugs: the investigational drugs journal 3(8): 856
Muhsin, M.; Nitsche, F. 2000: ASCO - 36th Meeting. Scientific symposia, press briefings and poster sessions. IDrugs: the investigational drugs journal 3(8): 851-855
Longo, F.; Mansueto, G.; Colucci, G. 2003: ASCO 2003--What is changing in the treatment of colorectal cancer. Tumori 89(4): 13-25
He, S.; Li, X.; Wu, Y.; Wu, S.; Wu, Z.; Yang, A.; Tong, P.; Yuan, J.; Gao, J.; Chen, H. 2018: A novel sandwich enzyme-linked immunosorbent assay with covalently bound monoclonal antibody and gold probe for sensitive and rapid detection of bovine β-lactoglobulin. Analytical and Bioanalytical Chemistry 410(16): 3693-3703
Fu, J.; Wang, Z.; Luo, W.; Xing, S.; Lv, P.; Wang, Z.; Yuan, Z. 2018: Novel Sanger's Reagent-like Styrene Polymer for the Immobilization of Burkholderia cepacia Lipase. Acs Applied Materials and Interfaces 10(37): 30973-30982
Longo, F.; Mansueto, G. 2005: ASCO 2005: Progression with oxaliplatin in the treatment of colorectal neoplasms. Tumori 91(3): Suppl: 1-12
Penault-Llorca, F.éd.ér.; Bay, J.-O. 2005: ASCO 2005: biology has spoken!. Bulletin du Cancer 92(7): 623-624
Bonetti, A.; Cascinu, S.; Falcone, A.; Zaniboni, A. 2006: ASCO 2006 Annual Meeting, Atlanta, June 2-6, 2006. Focus on gastrointestinal tumors. Tumori 92(4): Suppl. 10-43
Locker, G.Y.; Hamilton, S.; Harris, J.; Jessup, J.M.; Kemeny, N.; Macdonald, J.S.; Somerfield, M.R.; Hayes, D.F.; Bast, R.C. 2006: ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 24(33): 5313-5327
Perrone, F. 2006: ASCO 2006. Exemestane: a new drug for the adjuvant therapy of breast cancer. Tumori 92(4): Suppl: 1-9
Li, M.; Tang, L.; Liao, Z.; Luo, J.; Wu, F.; Pan, Y.; Wang, J. 2018: A novel scaffolding algorithm based on contig error correction and path extension. Ieee/Acm Transactions on Computational Biology and Bioinformatics 2018
Pentz, R.D.; Joffe, S.; Emanuel, E.J.; Schnipper, L.E.; Haskell, C.M.; Tannock, I.F. 2006: ASCO core values. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 24(36): 5780-5782
Horning, S.J. 2006: ASCO core values: essential to progress in innovative, quality cancer care. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 24(36): 5629
Johnson, D.H. 2006: ASCO in the 21st century: challenges and opportunities--ASCO presidential address 2005. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 24(13): 1967-1971
Makarenko, S.; Ye, V.; Gooderham, P.A.; Akagami, R. 2018: A novel scale for describing visual outcomes in patients following resection of lesions affecting the optic apparatus: the Unified Visual Function Scale. Journal of Neurosurgery 129(6): 1438-1445
Vinay, K.; Dabas, G.; Parsad, D.; Kumaran, M.S. 2018: A novel scale for measurement of acquired dermal macular hyperpigmentation severity. Journal of the European Academy of Dermatology and Venereology: Jeadv 32(6): E251-E253
Fiers, M.; Golemiec, E.; van der Schors, R.; van der Geest, L.; Li, K.W.; Stiekema, W.J.; Liu, C.-M. 2006: The CLAVATA3/ESR motif of CLAVATA3 is functionally independent from the nonconserved flanking sequences. Plant Physiology 141(4): 1284-1292
Schlegel, M.; Coburger, P.; Schneider, C. 2018: A Novel Sc(OTf)3 -Catalyzed (2+2+1)-Cycloannulation/Aza-Friedel-Crafts Alkylation Sequence toward Multicyclic 2-Pyrrolines. Chemistry 24(53): 14207-14212
Guillem, J.é G.; Wood, W.C.; Moley, J.F.; Berchuck, A.; Karlan, B.Y.; Mutch, D.G.; Gagel, R.F.; Weitzel, J.; Morrow, M.; Weber, B.L.; Giardiello, F.; Rodriguez-Bigas, M.A.; Church, J.; Gruber, S.; Offit, K. 2006: ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 24(28): 4642-4660
Anonymous 1954: ASCORBIC acid and ACTH in experimental wounds. Nutrition Reviews 12(4): 124-126
Anonymous 1957: ASCORBIC acid and bioflavonoids. Nutrition Reviews 15(7): 209-210
Anonymous 1958: ASCORBIC acid and collagen formation. Nutrition Reviews 16(7): 218-220
Anonymous 1950: ASCORBIC acid and desoxycorticosterone in rheumatic disease. Nutrition Reviews 8(9): 276-278
Anonymous 1952: ASCORBIC acid and the conversion of pteroylglutamic acid to Citrovorum factor. Nutrition Reviews 10(2): 40-42
Anonymous 1953: ASCORBIC acid as a coenzyme. Nutrition Reviews 11(1): 17-18
Jaffe, H.L.; Ottoman, R.E. 1950: Evaluation of radioiodine test for thyroid function. Journal of the American Medical Association 143(6): 515-519
Anonymous 1958: ASCORBIC acid in maternal nutrition. Nutrition Reviews 16(1): 6-7
Anonymous 1959: ASCORBIC acid in serum. Nutrition Reviews 17(3): 75-76
Anonymous 1960: ASCORBIC acid in the parental diet and calcium utilization by the chick. Nutrition Reviews 18: 188-190
Anonymous 1957: ASCORBIC acid requirement with periodic administration. Nutrition Reviews 15(8): 244-245
Anonymous 1954: ASCORBIC acid synthesis in animals. Nutrition Reviews 12(5): 155-156
Pegoraro, R.J.; Ranjith, N. 2005: Plasminogen activator inhibitor type 1 (PAI-1) and platelet glycoprotein IIIa (PGIIIa) polymorphisms in young Asian Indians with acute myocardial infarction. Cardiovascular Journal of South Africa: Official Journal for Southern Africa Cardiac Society and South African Society of Cardiac Practitioners 16(5): 266-270
Kjeldsen, S.E.; Narkiewicz, K.; Hedner, T. 2005: ASCOT - more than a horse race!. Blood Pressure 14(5): 262-263
Pasierski, T. 2005: ASCOT Study confirms the benefit of new classes of hypotensive drugs. Kardiologia Polska 63(4): 438-440
Ahmed, A.R.; Sharma, A.; Wellwood, J. 2005: An unusual abdominal wall hernia. Annals of the Royal College of Surgeons of England 87(5): W1-W2
Sever, P. 2005: ASCOT a four horse race. Journal of the Renin-Angiotensin-Aldosterone System: Jraas 6(2): 51-54
Valtchanova-Matchouganska, A.; Gondwe, M.; Nadar, A. 2005: C-reactive protein in acute and delayed preconditioning of the rat heart. Cardiovascular Journal of South Africa: Official Journal for Southern Africa Cardiac Society and South African Society of Cardiac Practitioners 16(2): 118-123
Inglis, T.J.J.; Rolim, D.B.; Rodriguez, J.L.N. 2006: Clinical guideline for diagnosis and management of melioidosis. Revista do Instituto de Medicina Tropical de Sao Paulo 48(1): 1-4
Ritter, J.; Warren, J. 2006: ASCOT--old or new drugs for blood pressure?. British Journal of Clinical Pharmacology 61(3): 363
Anonymous 2005: ASCOT-BPLA Study raises new questions regarding: which is the best initial antihypertensive drug?. MMW Fortschritte der Medizin 147(39): 12
Rayner, B. 2005: ASCOT-BPLA signals changes to hypertension guidelines. Cardiovascular Journal of South Africa: Official Journal for Southern Africa Cardiac Society and South African Society of Cardiac Practitioners 16(5): 244-245
Liebson, P.R. 2006: ASCOT-Blood Pressure Trial (ASCOT-BPLA) and HOPE-TOO. Preventive Cardiology 9(1): 60-63
Nambi, V.; Ballantyne, C.M. 2004: ASCOT-LLA and the primary prevention of coronary artery disease in hypertensive patients. Current Atherosclerosis Reports 6(5): 353-358
Ravnskov, U. 2003: ASCOT-LLA: questions about the benefits of atorvastatin. Lancet 361(9373): 1986; Author Reply 1986-7
McDougall, C.; Brady, A.J.B.; Petrie, J.R. 2005: ASCOT: a tale of two treatment regimens. Bmj 331(7521): 859-860
Phizackerley, D.G. 2005: ASCOT: a tale of two treatment regimens: don't lose your head over ASCOT. Bmj 331(7523): 1022
Cave, J.A. 2005: ASCOT: a tale of two treatment regimens: is ASCOT all it's cracked up to be?. Bmj 331(7523): 1023
Burrill, P.D. 2005: ASCOT: a tale of two treatment regimens: is ASCOT-BPLA being hyped-up?. Bmj 331(7523): 1022
Steinert, R.F.; Binkhorst, C. 2005: ASCRS Binkhorst lecture 2004: the search for perfect vision: ophthalmology's Holy Grail?. Journal of Cataract and Refractive Surgery 31(12): 2405-2412
Donnenfeld, E.D.; Kim, T.; Holland, E.J.; Azar, D.T.; Palmon, F.Rick.; Rubenstein, J.B.; Daya, S.; Yoo, S.H. 2005: ASCRS White Paper: Management of infectious keratitis following laser in situ keratomileusis. Journal of Cataract and Refractive Surgery 31(10): 2008-2011
Nichamin, L.D.; Chang, D.F.; Johnson, S.H.; Mamalis, N.; Masket, S.; Packard, R.B.; Rosenthal, K.J. 2006: ASCRS White Paper: What is the association between clear corneal cataract incisions and postoperative endophthalmitis?. Journal of Cataract and Refractive Surgery 32(9): 1556-1559
McGrath, C.M. 2002: ASCUS in Papanicolaou smears. Problems, controversies, and potential future directions. American Journal of Clinical Pathology 117 Suppl: S62-S75
Teleman, S.; Anton, C.; Socolov, D.; Ungureanu, C.; Danciu, M.; Mihailovici, M.S. 2004: ASCUS of metaplastic type. Cyto-histopathological correlations. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 108(1): 85-89
Boulanger, J-C.; Sevestre, H. 2006: ASCUS: an update. Gynecologie Obstetrique and Fertilite 34(1): 44-48
Deery, A. 2003: ASCUS; borderline changes; epithelial abnormality; Pap class III -- what's in a name?. Cytopathology: Official Journal of the British Society for Clinical Cytology 14(5): 231-234
Vervoort, G.; Wetzels, J.F.M. 2006: Hyponatremia: effective treatment based on calculated outcomes. Nederlands Tijdschrift Voor Geneeskunde 150(39): 2121-2126
Flowers, L. 2006: Inexpensive ideas to keep staff happy. Or Manager 22(9): 30
Mathias, J.M.; Patterson, P. 2005: ASCs fine-tune preoperative process. Or Manager 21(1): 27-28
Cool, D.R.; Hardiman, A. 2004: C-terminal sequencing of peptide hormones using carboxypeptidase y and SELDI-TOF mass spectrometry. Biotechniques 36(1): 32-34
Flowers, L. 2005: ASCs voice concerns to CMS on Medicare reimbursement. Or Manager 21(10): 40; 42 44 Passim
Gupta, V.Kumar. 2005: ASD closure for migraine: is there a scientific basis?. European Heart Journal 26(14): 1446; Author Reply 1446-7
Faella, H.J.; Sciegata, A.M.; Alonso, J.é L.; Jmelnitsky, L. 2003: ASD closure with the Amplatzer device. Journal of Interventional Cardiology 16(5): 393-397
Sieroń, A.L.; Stańczak, P.ł 2006: ASD--lessons on genetic background from transgenic mice with inactive gene encoding metalloprotease, Tolloid-like 1 (TLL1). Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 12(1): Ra17-Ra22
Baudino, C. 1956: ASD. II. Angiocardio hemodynamic aspects and graphics. Revista Medica de Cordoba 44: 278-287
Svedman, K.J.; Coldiron, B.; Coleman, W.P.; Cox, S.Ellen.; Jacob, C.; Lawrence, N.; Kaminer, M.; Narins, R.S. 2006: ASDS guidelines of care for tumescent liposuction. Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery 32(5): 709-716
Ashraf, H. 2003: ASEAN leaders agree regional SARS plan. Lancet 361(9368): 1525
Hollinger, H.Z.; Pattee, C.J. 1957: A review of calcium and phosphorus metabolism. II. Hypocalcaemia. Canadian Medical Association Journal 77(1): 45-53
Hohf, R.P. 1953: Present status of cancer chemotherapy. Medical Times 81(1): 1-6
Lamarche, B.J.; Kumar, S.; Tsai, M-Daw. 2006: ASFV DNA polymerse X is extremely error-prone under diverse assay conditions and within multiple DNA sequence contexts. Biochemistry 45(49): 14826-14833
Qureshi, W.A.; Rajan, E.; Adler, D.G.; Davila, R.E.; Hirota, W.K.; Jacobson, B.C.; Leighton, J.A.; Zuckerman, M.J.; Hambrick, R.David.; Fanelli, R.D.; Baron, T.; Faigel, D.O. 2005: ASGE Guideline: Guidelines for endoscopy in pregnant and lactating women. Gastrointestinal Endoscopy 61(3): 357-362
Qureshi, W.; Adler, D.G.; Davila, R.; Egan, J.; Hirota, W.; Leighton, J.; Rajan, E.; Zuckerman, M.J.; Fanelli, R.; Wheeler-Harbaugh, J.; Baron, T.H.; Faigel, D.O. 2005: ASGE Guideline: the role of endoscopy in the management of variceal hemorrhage, updated July 2005. Gastrointestinal Endoscopy 62(5): 651-655
Davila, R.E.; Rajan, E.; Adler, D.G.; Egan, J.; Hirota, W.K.; Leighton, J.A.; Qureshi, W.; Zuckerman, M.J.; Fanelli, R.; Wheeler-Harbaugh, J.; Baron, T.H.; Faigel, D.O. 2005: ASGE Guideline: the role of endoscopy in the patient with lower-Gi bleeding. Gastrointestinal Endoscopy 62(5): 656-660
Croffie, J.; Carpenter, S.; Chuttani, R.; DiSario, J.; Hussain, N.; Liu, J.; Mishkin, D.; Somogyi, L.; Tierney, W.; Petersen, B.T. 2005: ASGE Technology Status Evaluation Report: disposable endoscopic accessories. Gastrointestinal Endoscopy 62(4): 477-479
Mishkin, D.; Carpenter, S.; Croffie, J.; Chuttani, R.; DiSario, J.; Hussain, N.; Liu, J.; Somogyi, L.; Tierney, W.; Petersen, B.T. 2005: ASGE Technology Status Evaluation Report: radiographic contrast media used in ERCP. Gastrointestinal Endoscopy 62(4): 480-484
Mishkin, D.S.; Chuttani, R.; Croffie, J.; Disario, J.; Liu, J.; Shah, R.; Somogyi, L.; Tierney, W.; Song, L.M.Wong.Kee.; Petersen, B.T. 2006: ASGE Technology Status Evaluation Report: wireless capsule endoscopy. Gastrointestinal Endoscopy 63(4): 539-545
Chotiprashidi, P.; Liu, J.; Carpenter, S.; Chuttani, R.; DiSario, J.; Hussain, N.; Somogyi, L.; Petersen, B.T. 2005: ASGE Technology Status Evaluation Report: wireless esophageal pH monitoring system. Gastrointestinal Endoscopy 62(4): 485-487
Adler, D.G.; Leighton, J.A.; Davila, R.E.; Hirota, W.K.; Jacobson, B.C.; Qureshi, W.A.; Quereshi, W.A.; Rajan, E.; Zuckerman, M.J.; Fanelli, R.D.; Hambrick, R.D.; Baron, T.; Faigel, D.O. 2004: ASGE guideline: the role of endoscopy in acute non-variceal upper-Gi hemorrhage. Gastrointestinal Endoscopy 60(4): 497-504
Jacobson, B.C.; Baron, T.H.; Adler, D.G.; Davila, R.E.; Egan, J.; Hirota, W.K.; Leighton, J.A.; Qureshi, W.; Rajan, E.; Zuckerman, M.J.; Fanelli, R.; Wheeler-Harbaugh, J.; Faigel, D.O. 2005: ASGE guideline: the role of endoscopy in the diagnosis and the management of cystic lesions and inflammatory fluid collections of the pancreas. Gastrointestinal Endoscopy 61(3): 363-370
Davila, R.E.; Rajan, E.; Baron, T.H.; Adler, D.G.; Egan, J.V.; Faigel, D.O.; Gan, S.-I.; Hirota, W.K.; Leighton, J.A.; Lichtenstein, D.; Qureshi, W.A.; Shen, B.; Zuckerman, M.J.; VanGuilder, T.; Fanelli, R.D. 2006: ASGE guideline: colorectal cancer screening and surveillance. Gastrointestinal Endoscopy 63(4): 546-557
Adler, D.G.; Jacobson, B.C.; Davila, R.E.; Hirota, W.K.; Leighton, J.A.; Qureshi, W.A.; Rajan, E.; Zuckerman, M.J.; Fanelli, R.D.; Baron, T.H.; Faigel, D.O. 2005: ASGE guideline: complications of EUS. Gastrointestinal Endoscopy 61(1): 8-12
Leighton, J.A.; Shen, B.; Baron, T.H.; Adler, D.G.; Davila, R.; Egan, J.V.; Faigel, D.O.; Gan, S.-I.; Hirota, W.K.; Lichtenstein, D.; Qureshi, W.A.; Rajan, E.; Zuckerman, M.J.; VanGuilder, T.; Fanelli, R.D. 2006: ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointestinal Endoscopy 63(4): 558-565
Qureshi, W.; Adler, D.G.; Davila, R.E.; Egan, J.; Hirota, W.K.; Jacobson, B.C.; Leighton, J.A.; Rajan, E.; Zuckerman, M.J.; Fanelli, R.; Wheeler-Harbaugh, J.; Baron, T.H.; Faigel, D.O. 2005: ASGE guideline: guideline on the use of endoscopy in the management of constipation. Gastrointestinal Endoscopy 62(2): 199-201
Faigel, D.O.; Baron, T.H.; Adler, D.G.; Davila, R.E.; Egan, J.; Hirota, W.K.; Jacobson, B.C.; Leighton, J.A.; Qureshi, W.; Rajan, E.; Zuckerman, M.J.; Fanelli, R.; Wheeler-Harbaugh, J. 2005: ASGE guideline: guidelines for credentialing and granting privileges for capsule endoscopy. Gastrointestinal Endoscopy 61(4): 503-505
Qureshi, W.A.; Zuckerman, M.J.; Adler, D.G.; Davila, R.E.; Egan, J.V.; Gan, S.I.; Lichtenstein, D.R.; Rajan, E.; Shen, B.; Fanelli, R.D.; Van Guilder, T.; Baron, T.H. 2006: ASGE guideline: modifications in endoscopic practice for the elderly. Gastrointestinal Endoscopy 63(4): 566-569
Zuckerman, M.J.; Hirota, W.K.; Adler, D.G.; Davila, R.E.; Jacobson, B.C.; Leighton, J.A.; Qureshi, W.A.; Rajan, E.; Hambrick, R.David.; Fanelli, R.D.; Baron, T.H.; Faigel, D.O. 2005: ASGE guideline: the management of low-molecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures. Gastrointestinal Endoscopy 61(2): 189-194
Adler, D.G.; Baron, T.H.; Davila, R.E.; Egan, J.; Hirota, W.K.; Leighton, J.A.; Qureshi, W.; Rajan, E.; Zuckerman, M.J.; Fanelli, R.; Wheeler-Harbaugh, J.; Faigel, D.O. 2005: ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointestinal Endoscopy 62(1): 1-8
Davila, R.E.; Rajan, E.; Adler, D.; Hirota, W.K.; Jacobson, B.C.; Leighton, J.A.; Qureshi, W.; Zuckerman, M.J.; Fanelli, R.; Hambrick, D.; Baron, T.H.; Faigel, D.O. 2005: ASGE guideline: the role of endoscopy in the diagnosis, staging, and management of colorectal cancer. Gastrointestinal Endoscopy 61(1): 1-7
Hirota, W.K.; Zuckerman, M.J.; Adler, D.G.; Davila, R.E.; Egan, J.; Leighton, J.A.; Qureshi, W.A.; Rajan, E.; Fanelli, R.; Wheeler-Harbaugh, J.; Baron, T.H.; Faigel, D.O. 2006: ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper Gi tract. Gastrointestinal Endoscopy 63(4): 570-580
Hogan, W.J. 2004: ASGE leadership: promoting or validating endoscopic technology?. Gastrointestinal Endoscopy 60(2): 323-4; Discussion 324
de la Torre Bravo, A. 2006: ASGE pleanry session. Revista de Gastroenterologia de Mexico 71 Suppl. 1: 125-126
Vader, J-Paul.; Froehlich, F.; Burnand, B.; Gonvers, J-Jacques. 2005: ASGE versus EPAGE versus diagnostic yield: a level playing field, please!. American Journal of Gastroenterology 100(8): 1892; Author Reply 1892-3
Hu, M.; Zhang, J.; Yang, J.; Cao, Y.; Qi, J. 2018: A Novel sc Fv Anti-Aβ Antibody Reduces Pathological Impairments in APP/PS1 Transgenic Mice via Modulation of Inflammatory Cytokines and Aβ-related Enzymes. Journal of Molecular Neuroscience: Mn 66(1): 1-9
Anonymous 1920: A Novel Scheme of Re-Organisation. Hospital 68(1773): 221-222
Palmer, K. 2000: ASGT - Third Meeting. Clinical and poster sessions. IDrugs: the investigational drugs journal 3(9): 1012-1015
Davis, J.L. 2000: ASGT - Third Meeting. Gene therapy. IDrugs: the investigational drugs journal 3(9): 1018-1020
Palmer, K. 2000: ASGT - Third Meeting. Recent advances in clinical gene therapy. IDrugs: the investigational drugs journal 3(9): 1016-1017
Strathdee, C.A. 2000: ASGT - Third Meeting. Stable gene delivery. IDrugs: the investigational drugs journal 3(9): 1021-1022
Cases, A. 2000: ASH news on hypertension. Drug News and Perspectives 13(5): 316-319
Carrion, A.L.; Ashford 1960: ASHFORD, man of multiple facets; his fondness for mycology. Boletin de la Asociacion Medica de Puerto Rico 52: 402-405
Anonymous 2004: ASHP Guidelines on the Pharmacist's Role in the Development, Implementation, and Assessment of Critical Pathways. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 61(9): 939-945
Myers, C.E. 2004: ASHP Health-System Pharmacy 2015 Initiative. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 61(7): 657
Anonymous 2005: ASHP Health-System Pharmacy 2015 Initiative: baseline statistics. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 62(13): 1393-1397
Zillich, A.J.; Haines, S.T. 2006: ASHP Therapeutic Position Statement on the Treatment of Hypertension. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 63(11): 1074-1080
Trovato, J.A.; Edwards, J.M. 2004: Education and training of pharmacy students. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 61(18): 1956-1957
Nickols, J.L. 2004: ASHP Virtual Mentoring Exchange program. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 61(3): 236-238
Anonymous 2003: ASHP guidelines on documenting pharmaceutical care in patient medical records. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 60(7): 705-707
Adra, M.; Decker, E.L. 2003: Patient safety mandates: a means to an end?. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 60(13): 1379-1381
Sleath, B.; Bush, P.J.; Pradel, F.G. 2003: Communicating with children about medicines: a pharmacist's perspective. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 60(6): 604-607
Pedersen, C.A.; Schneider, P.J.; Scheckelhoff, D.J. 2006: ASHP national survey of pharmacy practice in hospital settings: dispensing and administration--2005. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 63(4): 327-345
Pedersen, C.A.; Schneider, P.J.; Scheckelhoff, D.J. 2004: ASHP national survey of pharmacy practice in hospital settings: monitoring and patient education--2003. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 61(5): 457-471
Pedersen, C.A.; Schneider, P.J.; Scheckelhoff, D.J. 2007: ASHP national survey of pharmacy practice in hospital settings: monitoring and patient education--2006. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 64(5): 507-520
Pedersen, C.A.; Schneider, P.J.; Scheckelhoff, D.J. 2005: ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2004. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 62(4): 378-390
Traynor, K.; Beckerman, J. 2007: ASHP past President Joseph Beckerman dies at 91. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 64(6): 580-581
Lifshin, L.S.; Teeters, J.L.; Bush, C.G. 2004: ASHP resident matching program: how does it work?. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 61(5): 446
Manasse, H.R. 2005: ASHP s 2015 initiative: a collective effort to improve pharmacy practice in hospitals and health-systems in the United States. Farmacia hospitalaria: organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 29(6): 349-350
Bianchi, G. 2005: Genetic variations of tubular sodium reabsorption leading to "primary" hypertension: from gene polymorphism to clinical symptoms. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 289(6): R1536-R1549
Anonymous 2003: ASHP statement on the pharmacist's role in the care of patients with HIV infection. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 60(19): 1998-2003
Anonymous 2003: ASHP statement on the role of health-system pharmacists in emergency preparedness. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 60(19): 1993-1995
Knapp, K.K.; Okamoto, M.P.; Black, B.L. 2005: ASHP survey of ambulatory care pharmacy practice in health systems--2004. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 62(3): 274-284
Ray, M.D. 2003: A pharmacist's reflections on Calvino's Six memos. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 60(22): 2363-2365
Dopheide, J.A. 2005: ASHP therapeutic position statement on the appropriate use of medications in the treatment of attention-deficit/hyperactivity disorder in pediatric patients. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 62(14): 1502-1509
Saseen, J.J. 2005: ASHP therapeutic position statement on the daily use of aspirin for preventing cardiovascular events. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 62(13): 1398-1405
Johnson, P.E.; Hayes, J.M. 2006: Medication use in schools. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 63(13): 1277-1285
Anonymous 2003: ASHP therapeutic position statement on the use of statins in the prevention of atherosclerotic vascular disease in adults. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 60(6): 593-598
Miller, A.D.; Ball, A.M.; Smith, K.M.; McAllister, J.C. 2005: ASHP's clinical skills competition: a problem-solving framework. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 62(21): 2236-2238
Witmer, D.R. 2003: ASHP's new membership structure: growing communities. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 60(12): 1217
Maloney, L.R.; Thompson, K.K.; Vanderpool, H.K. 2005: ASHP's role in eliminating health disparities. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 62(18): 1871
Young, D. 2006: ASHP, ABHP sign cooperation pact. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 63(2): 110 112
Young, D. 2003: ASHP, other groups, advise FDA about solving counterfeit drug problems. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 60(23): 2406 2408 2411
Anonymous 1958: ASIAN influenza in Santiago and Concepción, Chile; observations on the epidemic during July and August, 1957. Journal of the American Medical Association 167(3): 290-297
Anonymous 1958: ASIAN influenza: retrospect and prospect. New England Journal of Medicine 259(25): 1229-1231
Scheimer, O.M. 1957: Chiropodical management of infantile metatarsus varus. Journal of the National Association of Chiropodists 47(9): 435-442
Anonymous 1957: ASIAN influenza; a special report to medical societies. Journal of the American Medical Association 165(6): 691-693
Rusk, H.A.; Dacso, M.M. 1957: Rehabilitation and restorative services. Journal of the American Medical Association 165(4): 360-362
Anonymous 1957: ASIAN strain of influenza A. Public Health Reports 72(9): 768-770
Rigler, L.G. 1957: A roentgen study of the evolution of carcinoma of the lung. Journal of Thoracic Surgery 34(3): 283-297; Discussion: 307-309
Immke, D.C.; McCleskey, E.W. 2001: ASIC3: a lactic acid sensor for cardiac pain. Thescientificworldjournal 1: 510-512
Dobre, I.; Croitoriu, M.-G.; Basca, N.; Oraseanu, D. 2002: ASISTASTM telematic assistance for chronic asthma. Studies in Health Technology and Informatics 90: 201-205
Ichijo, H. 2007: ASK family proteins in stress and disease--"how cells sense stress". Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 129(2): 89-93
Abello, J.; van Ham, F.; Krishnan, N. 2006: ASK-GraphView: A large scale graph visualization system. IEEE Transactions on Visualization and Computer Graphics 12(5): 669-676
Faigle, R.; Brederlau, A.; Elmi, M.; Arvidsson, Y.; Hamazaki, T.S.; Uramoto, H.; Funa, K. 2004: ASK1 inhibits astroglial development via p38 mitogen-activated protein kinase and promotes neuronal differentiation in adult hippocampus-derived progenitor cells. Molecular and Cellular Biology 24(1): 280-293
Chiappo, G.F.; Mignone, F.; Remogna, M.; Zannino, L. 1973: ASLO levels in 1174 patients admitted to the Turin University Paediatrics Clinic during the period 1996-1972. Archivio Per le Scienze Mediche 130(4): 248-263
Chiappo, G.F.; Mignone, F.; Remogna, M. 1973: ASLO values as a pointer to rheumatism. Archivio Per le Scienze Mediche 130(4): 270-272
Kwaik, Y.A. 2000: ASM - 100th Meeting. Fluoroquinolones and other antimicrobial agents. IDrugs: the investigational drugs journal 3(8): 865-867
Nelson, J. 2000: ASM - 100th Meeting. Vaccine developments and highlights of poster sessions. IDrugs: the investigational drugs journal 3(8): 861-864
Weissfeld, A.S. 2004: ASM's role in writing practice guidelines. Journal of clinical microbiology 42(11): 5436; author reply 5436
Anand, T.; Kumar, A.S.K.; Sahoo, S.K. 2018: A novel Schiff base derivative of pyridoxal for the optical sensing of Zn2+ and cysteine. Photochemical and Photobiological Sciences: Official Journal of the European Photochemistry Association and the European Society for Photobiology 17(4): 414-422
Varner, J.M. 2004: ASNA independent study activity--compassion fatigue. Alabama Nurse 31(1): 30; Quiz 31
Roberson, C.M. 2003: ASNA independent study activity--cultural assessment of Koreans. Alabama Nurse 30(3): 13-14; Quiz: 15-16
Varner, J.M. 2003: ASNA independent study activity--substance abuse and the older adult. Alabama Nurse 30(4): 15-16
Johnson, M.R. 2005: ASNA independent study activity: "Selective serotoni inhibitors (SSRIs)--what nurses should know". Nebraska Nurse 38(1): 30; Quiz 31
Roberson, C.M. 2004: ASNA independent study. Fibromyalgia. Alabama Nurse 31(2): 22-24; Quiz: 24-25
Kao, G.; Nordenson, C.; Still, M.; Rönnlund, A.; Tuck, S.; Naredi, P. 2007: ASNA-1 positively regulates insulin secretion in C. elegans and mammalian cells. Cell 128(3): 577-587
Karray, M.; Kooli, M.; Ezzaouia, K.; Bouzidi, R.; Mestiri, M.; Zlitni, M. 2004: Predictive criterions of unrecognized articular effraction after internal fixation of femoral neck fractures. La Tunisie Medicale 82(9): 827-836
Pohjonen, H.; Kauppinen, T.; Ahovuo, J. 2004: ASP archiving solution of regional HUSpacs. European Radiology 14(9): 1702-1706
Smith, G. 2004: ASP's new prevention department. Survival News 15(6): 5 21
Newhouse, R. 2006: ASPAN and the organizational EBP vision: synergistic opportunities for perianesthesia nurses. Journal of Perianesthesia Nursing: Official Journal of the American Society of Perianesthesia Nurses 21(3): 190-194
Windle, P.E.; Kwan, M.L.; Warwick, H.; Sibayan, A.; Espiritu, C.; Vergara, J. 2006: Comparison of bacteriostatic normal saline and lidocaine used as intradermal anesthesia for the placement of intravenous lines. Journal of Perianesthesia Nursing: Official Journal of the American Society of Perianesthesia Nurses 21(4): 251-258
Mamaril, M.E.; Ross, J.M.; Krenzischek, D.; O'Brien, D.; Wilson, L.; Clark, M.; Clifford, T.; Hooper, V. 2006: ASPAN's [corrected] EBP conceptual model: framework for perianesthesia practice and research. Journal of Perianesthesia Nursing: Official Journal of the American Society of Perianesthesia Nurses 21(3): 157-167
Lam, M.F.; Tang, C.; Wong, A.K.; Tong, K.L.; Yu, A.W.; Li, C.S.; Cheung, K.O.; Lai, K.N. 2006: ASPD: a prospective study of adequacy in Asian patients on long term, small volume, continuous ambulatory peritoneal dialysis. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 26(4): 466-474
Demaerschalk, B.M.; Silver, B.; Wong, E.; Merino, J.G.; Tamayo, A.; Hachinski, V. 2006: ASPECT scoring to estimate >1/3 middle cerebral artery territory infarction. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 33(2): 200-204
Anonymous 1953: ASPECTS of enzyme research. Lancet 265(6779): 241
Anonymous 1951: ASPECTS of flying. British Medical Journal 2(4733): 722-723
Anonymous 1953: ASPECTS of general practice. Journal of the American Osteopathic Association 52(10): 523-524
Coutts, S.B.; Hill, M.D.; Demchuk, A.M.; Barber, P.A.; Pexman, J.H.Warwick.; Buchan, A.M. 2003: ASPECTS reading requires training and experience. Stroke 34(10): E179; Author Reply E179
Balas, A.E.; Ramiah, K.; Martin, K. 2004: ASPH/American Legacy Foundation STEP UP Program: An innovative partnership for tobacco studies in the schools of public health. Public Health Reports 119(3): 380-385
Goodman, J.; Simmons, N. 2002: ASPHER PEER review: a discussion of its role in the joint Open Society Institute (OSI)--Association of Schools of Public Health in the European Region (ASPHER) program. Public health reviews 30(1-4): 51-67
Anonymous 1951: ASPIRATION pneumonia. British Medical Journal 2(4738): 1018-1019
Anonymous 1953: ASPIRATION pneumonia and bronchiectasis. British Medical Journal 1(4802): 147-148
Anonymous 1958: ASPIRIN and diabetes. Nutrition Reviews 16(6): 167-168
Anonymous 1960: ASPIRIN and mercury intoxication and lye poisonings. New York State Journal of Medicine 60: 2305-2310
Anonymous 1958: ASPIRIN and muscle metabolism. Nutrition Reviews 16(9): 281-282
King, A.J. 1959: Drugs in the treatment of syphilis. i. British Medical Journal 1(5118): 355-357
Anonymous 2004: ASPMN position statement: pain management in patients with addictive disease. Journal of vascular nursing: official publication of the Society for Peripheral Vascular Nursing 22(3): 99-101
Liu, Z.-J.; Lu, X.; Zhong, S. 2005: ASPP--Apoptotic specific regulator of p53. Biochimica et Biophysica Acta 1756(1): 77-80
Spencer, K.W. 2005: Personalizing my own strategic recruitment plan. Plastic Surgical Nursing: Official Journal of the American Society of Plastic and Reconstructive Surgical Nurses 25(2): 59-60
Athanaselis, T.; Bakamidis, S.; Dologlou, I.; Cowie, R.; Douglas-Cowie, E.; Cox, C. 2005: ASR for emotional speech: clarifying the issues and enhancing performance. Neural Networks: the Official Journal of the International Neural Network Society 18(4): 437-444
Wang, H.; Fang, B.; Kong, L.; Li, X.; Feng, Z.; Wu, Y.; Uvdal, K.; Hu, Z. 2018: A novel Schiff base derivative: Synthesis, two-photon absorption properties and application for bioimaging. Spectrochimica Acta. Part a Molecular and Biomolecular Spectroscopy 198: 304-308
Curto, M.; Pompili, E.; Silvestrini, C.; Bellizzi, P.; Navari, S.; Pompili, P.; Manzi, A.; Bianchini, V.; Carlone, C.; Ferracuti, S.; Nicolò, G.; Baldessarini, R.J. 2018: A novel SCL-90-R six-item factor identifies subjects at risk of early adverse outcomes in public mental health settings. Psychiatry Research 267: 376-381
Haberl, R. 2003: ASS and dipyridamole combination. A decisive contribution to secondary prevention after stroke. MMW Fortschritte der Medizin 145 Suppl. 2: 98
Nitschmann, S.; Mössner, J. 2005: ASS or clopidogrel plus esomeprazole after bleeding from an ulcer. Der Internist 46(12): 1405-1408
Anonymous 2004: ASS plus dipyridamole instead of ASS monotherapy. Risk for second stroke cut in half. MMWFortschrittederMedizin 146(27-28): 55
Becker, J.H.R. 2005: ASSA presidential address. No man is an island. ASSA-SAGES Congress, Cape Town, 7 August 2004. SouthAfricanJournalofSurgery.Suid-AfrikaanseTydskrifVirChirurgie 43(1): 24
Anonymous 1951: ASSAULT and battery: necessity for consent for sterilization operation. Journal of the American Medical Association 145(13): 1005
Anonymous 1955: ASSAY of poliomyelitis vaccines. British Medical Journal 1(4923): 1204
Anonymous 1957: ASSAYS of unidentified chick growth factors. Nutrition Reviews 15(3): 82-84
McCauley, J.; Jenckes, M.W.; McNutt, L.-A. 2003: ASSERT: the effectiveness of a continuing medical education video on knowledge and attitudes about interpersonal violence. Academic Medicine: Journal of the Association of American Medical Colleges 78(5): 518-524
Anonymous 1951: ASSESSING the components of body weight in living persons. Nutrition Reviews 9(10): 299-300
Boyer, F.; Saviard, M. 1957: Experimental study of new alkylamino derivatives of DDS. Bulletin de la Societe de Pathologie Exotique et de Ses Filiales 50(4): 607-617
Gofton, J.P.; Thomas, J.W.; Robinson, H.S. 1957: Serological reactions to polysaccharides in rheumatoid arthritis. Canadian Medical Association Journal 77(12): 1098-1102
Anonymous 1952: ASSESSMENT of growth and development in children. Nutrition Reviews 10(9): 266-268
Anonymous 1951: ASSESSMENT of the amino acid composition and nutritional value of protein. Nutrition Reviews 9(2): 56-58
Anonymous 1955: ASSESSMENT of the energy value of human and animal foods. Proceedings of the Nutrition Society 14(2): 130-160
Davey, E.N.; Taylor, J.; Waite, J. 1957: A new Salmonella serotype, Salmonella gloucester. Monthly Bulletin of the Ministry of Health and the Public Health Laboratory Service 16: 14-16
Anonymous 1960: ASSESSMENT of weight reduction. Nutrition Reviews 18: 170-171
Anonymous 1955: ASSESSMENT, etiology and effects of obesity. Nutrition Reviews 13(2): 37-40
Anonymous 1957: ASSISTANCE for dental diagnostic and treatment facilities. Public Health Reports 72(11): 962
Foxman, B.T. 2018: A Novel Scleral Depressor for use in Vitrectomy Surgery. Retina 38(11): 2275-2276
Anonymous 1957: ASSOCIATION Santafesina of Physicians. El Dia Medico 29(85): 3167 passim
Payne, B.F. 1951: Pathological complications following intraocular surgery. A.M.A. Archives of Ophthalmology 46(4): 466-471
Anonymous 1953: ASSOCIATION of American Medical Colleges; minutes of the proceedings, sixty-third annual meeting, November 10-11-12, 1952, Colorado Springs, Colorado. Journal of Medical Education 28(1): 41-91
Anonymous 1952: ASSOCIATION of American Physicians: constitution as amended May 3, 1949. Transactions of the Association of American Physicians 65: xxxvi
Anonymous 1954: ASSOCIATION of Anaesthetists of Great Britain and Ireland. British Journal of Anaesthesia 26(2): 151-152
Anonymous 1951: ASSOCIATION of Surgeons of India; eleventh annual conference, Madras, 1949. Indian Medical Gazette 86(2): 60-61
Anonymous 1952: ASSOCIATION of liver damage with obesity. Nutrition Reviews 10(11): 325-327
Thal, A. 1955: Selective renal vasospasm and ischemic renal necrosis produced experimentally with staphylococcal toxin: observations on the pathogenesis of bilateral cortical necrosis. American Journal of Pathology 31(2): 233-259
Anonymous 1960: ASSOCIATION recommendations of fiscal 1961 appropriations for dental health and research activities of U.S. Public Health Service. Journal of the American Dental Association 60: 757-763
Anonymous 1956: ASSOCIATION testifies on four congressional bills during week of April 9. Journal of the American Dental Association 52(6): 742-749
Black, J.T. 1952: A new premature nursery at Michael Reese Hospital. Hospitals 26(9): 83-91
Taylor, J. 1955: How management engineering can benefit you. Hospital Progress 36(8): 43; Passim
Menof, P. 1953: The cause of essential hypertension. South African Medical Journal 27(20): 418-423
Straus, B.; Torres, J.M. 1953: Use and abuse of blood transfusion. Journal of the American Medical Association 151(9): 699-702
Anonymous 1955: ASSOCIATION'S viewpoint on military and veteran dental care proposals. Journal of the American Dental Association 50(5): 557-561
Zeineh, J. 2004: AST and telepathology benefit labs. Mlo: Medical Laboratory Observer 36(6): 20; 22-23
Anonymous 1950: ASTAR'TE two-way stretch elastic stocking accepted. Journal of the American Medical Association 143(11): 971
Jackson, G. 2006: ASTEROID--when spinning a star leads to a collision with reality. International Journal of Clinical Practice 60(5): 505
Smith, L.O. 1959: Nursing in new Brunswick. Canadian Nurse 55(3): 199-200
Lepow, H.; Chu, F.; Muren, O. 1958: Multiple aneurysmal formation; an elastic tissue defect. American Journal of Medicine 24(4): 631-637
Grieve, A.P.; Krams, M. 2005: ASTIN: a Bayesian adaptive dose-response trial in acute stroke. Clinical Trials 2(4): 340-351; Discussion: 352-358; 364-378
Tessier, C. 2004: ASTM E31 Committee: recent activities address CCR, transcription and documentation, and security and privacy. Healthcare Informatics: the Business Magazine for Information and Communication Systems 21(9): 47-48
Ashley, K.; Harper, M. 2005: ASTM international standards for monitoring chemical hazards in workplaces. Journal of Occupational and Environmental Hygiene 2(6): D44-D47
Dixon, L.Mitchell. 2004: ASTM subcommittee D10.31 and poison prevention. Standardization News: Sn 32(2): 36-39
Coquard, R.ég. 2003: ASTRO 2002: results and perspectives for urologic cancers. Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 13(1): 160-162
Coquard, R.ég. 2004: ASTRO 2003: main lessons for clinical practice in urological oncology. Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 14(2): 246-248
Boddum, K.; Saljic, A.; Jespersen, T.; Christensen, A.H.ør. 2018: A Novel SCN5A Variant Associated with Abnormal Repolarization, Atrial Fibrillation, and Reversible Cardiomyopathy. Cardiology 140(1): 8-13
Salmeron, S. 2005: ASUR-ASUR2: an overview of the standardisation of treatment of acute asthma in intensive care. Revue des Maladies Respiratoires 22(2 Part 3): 4s30-4s31
Anonymous 1960: ASYMPTOMIC bacteria. Lancet 1(7136): 1231-1232
Brillinger, D.R.; Rosenblatt, M. 1967: ASYMPTOTIC THEORY OF ESTIMATES OF kTH-ORDER SPECTRA. Proceedings of the National Academy of Sciences of the United States of America 57(2): 206-210
van der Heijde, D.; Braun, J.; Landewé, R.; Davis, J.; Sieper, J.; van der Linden, S.; Dougados, M. 2005: ASessment in Ankylosing Spondylitis (ASAS) international working group: a model for psoriatic arthritis and psoriasis?. Annals of the Rheumatic Diseases 64 Suppl. 2: Ii108-Ii109
Goetzinger, B.R.; Massion, W.H. 1963: ASnesthesia for adrenal srugery. American Surgeon 29: 227-232
van der Heijde, Désirée.; Dougados, M.; Davis, J.; Weisman, M.H.; Maksymowych, W.; Braun, Jürgen.; Hallegua, D.S.; Bruckel, J. 2005: ASsessment in Ankylosing Spondylitis International Working Group/Spondylitis Association of America recommendations for conducting clinical trials in ankylosing spondylitis. Arthritis and Rheumatism 52(2): 386-394
Dietz, R. 2004: AT 1-blocker can be given in addition to ACE inhibitor and beta blocker. "Triple therapy decidedly well tolerated even in severe heart failure". MMW Fortschritte der Medizin 146(22): 50
Anonymous 1956: AT RANCH style hospital; meal service on wheels. Canadian Hospital 33(9): 57
Anonymous 1959: AT THE core of cancer and viruses. British Medical Journal 1(5136): 1519-1520
Anonymous 1953: AT TRI-STATE, they learned more in the corridors. Modern Hospital 80(6): 57-8; Passim
Radisic, D.; Bowen, K.H.; Dabkowska, I.; Storoniak, P.; Rak, J.; Gutowski, M. 2005: AT base pair anions versus (9-methyl-A)(1-methyl-T) base pair anions. Journal of the American Chemical Society 127(17): 6443-6450
Anonymous 1953: AT good Samaritan we gutted the hospital. Modern Hospital 80(3): 75-77
Leong, T.; McKay, M. 2003: AT heterozygosity in a patient with multiple myeloma. Clinical Oncology 15(6): 367-368
Hadfield, G.J.; Heber, A.J. 1950: A portable anaesthetic apparatus for F.S.T. work. Journal of the Royal Army Medical Corps 95(3): 175-176
Anonymous 1959: AT the Centre Hospitalier de Nevers. An effort aimed at reorganization and modernization. Techniques Hospitalieres Medico-Sociales et Sanitaires 15: 64-70
Anonymous 1950: AT the Chelsea Babies' Club. Nursing Times 46(41): 1062-1063
Anonymous 1959: AT the Harare Hospital Staff Round. Case No. 11. Central African Journal of Medicine 5: 502-504
Anonymous 1959: AT the Harare Hospital Staff Round. Case No. 13. Central African Journal of Medicine 5: 504-505
Hasenfuss, G. 2004: AT(1) blocker for post-infarct therapy. VALIANT Study. Der Internist 45(8): 946-948
Crowley, S.D.; Gurley, S.B.; Coffman, T.M. 2007: AT(1) receptors and control of blood pressure: the kidney and more... Trends in Cardiovascular Medicine 17(1): 30-34
Pillau, H. 2003: Even as writers physicians remain physicians. Continued belletristic education. MMW Fortschritte der Medizin 145(15): 65
De Koning, S.; Kurano, M.; Janssen, H.-G.; Brinkman, U.A.T. 2004: AT-column, a novel concentrating technique for large-volume injections in gas chromatography. Journal of Chromatography. a 1023(2): 165-174
Siragy, H.M. 2004: AT1 and AT2 receptor in the kidney: role in health and disease. Seminars in Nephrology 24(2): 93-100
Einecke, D. 2004: AT1 blocker or calcium antagonist in treatment of hypertension. what protects the heart better?. MMW Fortschritte der Medizin 146(26): 12
Anonymous 2003: AT1 blocker therapy of hypertension in seniors. Added protection for cerebral blood vessels?. MMWFortschrittederMedizin 145(1-2): 53
Böhm, M. 2003: Therapy of heart failure. which patients does the AT1 blocker help?. MMW Fortschritte der Medizin 145(38): 8
Zivković, M.; Stanković, A.; Alavantić, D. 2005: AT1 receptor A1166C and AT2 receptor -1332A/G gene polymorphisms: efficient genotyping by single-tube PCR. Journal of Clinical Laboratory Analysis 19(2): 84-86
Dechend, R.; Müller, D.N.; Wallukat, G.; Homuth, V.; Krause, M.; Dudenhausen, J.; Luft, F.C. 2004: AT1 receptor agonistic antibodies, hypertension, and preeclampsia. Seminars in Nephrology 24(6): 571-579
Stiefelhagen, P. 2006: Significant thoracic pain after vomiting. MMW Fortschritte der Medizin 148(13): 61-62
Tokuhisa, T.; Yano, M.; Obayashi, M.; Noma, T.; Mochizuki, M.; Oda, T.; Okuda, S.; Doi, M.; Liu, J.; Ikeda, Y.; Yamamoto, T.; Ohkusa, T.; Matsuzaki, M. 2006: AT1 receptor antagonist restores cardiac ryanodine receptor function, rendering isoproterenol-induced failing heart less susceptible to Ca2+ -leak induced by oxidative stress. Circulation Journal: Official Journal of the Japanese Circulation Society 70(6): 777-786
Verheijen, I.; Vanderheyden, P.M.L.; De Backer, J.P.; Vauquelin, G. 2004: AT1 receptor antagonists. Current Medicinal Chemistry. Cardiovascular and Hematological Agents 2(1): 69-77
Jugdutt, B.I.; Sawicki, G. 2004: AT1 receptor blockade alters metabolic, functional and structural proteins after reperfused myocardial infarction: detection using proteomics. Molecular and Cellular Biochemistry 263(1-2): 179-188
Azadpour, M.; Lamas, G.A. 2004: AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction. Expert Review of Cardiovascular Therapy 2(6): 891-902
Vanourková, Z.; Kramer, H.J.; Husková, Z.; Vanecková, I.; Opocenský, M.; Chábová, V.Certíková.; Tesar, Vír.; Skaroupková, P.; Thumová, M.; Dohnalová, M.; Mullins, J.J.; Cervenka, L. 2006: AT1 receptor blockade is superior to conventional triple therapy in protecting against end-organ damage in Cyp1a1-Ren-2 transgenic rats with inducible hypertension. Journal of Hypertension 24(12): 2465-2472
Berthonneche, C.; Sulpice, T.; Tanguy, Séphane.; O'Connor, S.; Herbert, J-Marc.; Janiak, P.; de Leiris, Jël.; Boucher, Fçois. 2005: AT1 receptor blockade prevents cardiac dysfunction after myocardial infarction in rats. Cardiovascular Drugs and Therapy 19(4): 251-259
Akiyoshi, K.; Akimitsu, T.; Hara, M.; Saikawa, T.; Yoshimatsu, H. 2006: AT1 receptor blockade prevents microvascular dysfunction induced by ischemia/reperfusion injury. Journal of Atherosclerosis and Thrombosis 13(5): 231-239
Bellien, J.; Iacob, M.; Eltchaninoff, H.; Bourkaib, R.; Thuillez, C.; Joannides, R. 2007: AT1 receptor blockade prevents the decrease in conduit artery flow-mediated dilatation during NOS inhibition in humans. Clinical Science 112(7): 393-401
Oprisiu-Fournier, R.; Serot, J.-M.; Achard, J.-M.; Messerli, F.H.; Black, S.E.; Fournier, A. 2006: AT1 receptor blockers for cognition decline after cardiac surgery?. Stroke 37(11): 2666
Quitterer, U.; Lother, H.; Abdalla, S. 2004: AT1 receptor heterodimers and angiotensin Ii responsiveness in preeclampsia. Seminars in Nephrology 24(2): 115-119
Prieto-Carrasquero, M.C.; Kobori, H.; Ozawa, Y.; Gutiérrez, A.; Seth, D.; Navar, L.G. 2005: AT1 receptor-mediated enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. American Journal of Physiology. Renal Physiology 289(3): F632-F637
Waeber, B.; Burnier, M. 2003: AT1-receptor antagonism in hypertension: what has been learned with irbesartan?. Expert Review of Cardiovascular Therapy 1(1): 23-33
Schulz, R.; Heusch, G. 2003: AT1-receptor blockade in experimental myocardial ischemia/reperfusion. Clinical Nephrology 60(Suppl 1): S67-S74
Ruilope, L.M. 2000: AT1-receptor blockers and ACE inhibitors: alternatives or partners?. International Journal of Clinical Practice. Suppl 111: 20-24
Brown, M.J.; Mackenzie, I.S.; Ashby, M.J.; Balan, K.K.; Appleton, D.S. 2006: AT2 receptor stimulation may halt progression of pheochromocytoma. Annals of the new York Academy of Sciences 1073: 436-443
Baum, M.; Buzdar, A.; Howell, A. 2003: ATAC trial did not report interim results. Bmj 327(7422): 1050
de Castro, G. 2005: ATAC trial update. Lancet 365(9466): 1225; Author Reply 1225-6
Goodare, H.; Dimmer, C.; Page, K. 2003: ATAC trial: reporting interim results is not helpful. Bmj 326(7402): 1329
Zhang, Z.; Yamashita, H.; Toyama, T.; Sugiura, H.; Ando, Y.; Mita, K.; Hamaguchi, M.; Kawaguchi, M.; Miura, Y.; Iwase, H. 2005: ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(1): 193-198
Tollier, C.; Fusier, I.; Husson, M.-C. 2005: ATC and EphMRA classifications: evolution from 1996 to 2003 and comparative analysis. Therapie 60(1): 47-56
Evans, D.R. 1972: ATC displays. Applied Ergonomics 3(2): 114-117
Baker, S. 2005: ATC policy on the conservation of plants used in aromatherapy. Complementary Therapies in Clinical Practice 11(2): 137-138
Loft, S.; Hill, A.; Neal, A.; Humphreys, M.; Yeo, G. 2004: ATC-lab: an air traffic control simulator for the laboratory. Behavior Research Methods Instruments and Computers: a Journal of the Psychonomic Society Inc 36(2): 331-338
Chaki, S.; Yamaguchi, J.-i.; Yamada, H.; Thomsen, W.; Tran, T.-A.; Semple, G.; Sekiguchi, Y. 2005: ATC0175: an orally active melanin-concentrating hormone receptor 1 antagonist for the potential treatment of depression and anxiety. Cns Drug Reviews 11(4): 341-352
Verloop, M.C. 1957: ATCH and cortisone in hematology. Geneeskundige Gids 35(5): 73-84
Koestner, A.Jay. 2002: ATCN--a door to trauma nursing leadership. Journal of Trauma Nursing: the Official Journal of the Society of Trauma Nurses 9(1): 5